Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	tubulin binding	DCDC1 KIF1B APC SAXO2 SAXO1 TTLL7 DRG1 NF1 EML5 MARK4 DLEC1 TRAPPC14 SKA1 TBCEL	5.38e-05	428	187	14	GO:0015631
GeneOntologyMolecularFunction	ATP-dependent activity	MYO1G ERCC6 MYO19 SMCHD1 KIF1B ACSM1 SRCAP XRCC5 ERCC6L2 ACSM5 MTREX POLQ ATP2A1 DNAH5 ATP2A2 ATP2A3 SLC27A5	6.89e-05	614	187	17	GO:0140657
GeneOntologyMolecularFunction	P-type calcium transporter activity	ATP2A1 ATP2A2 ATP2A3	1.26e-04	11	187	3	GO:0005388
GeneOntologyMolecularFunction	cytoskeletal protein binding	MYO1G LARP6 DCDC1 MYO19 KIF1B APC SAXO2 SAXO1 MAPK8IP3 TTLL7 DRG1 NF1 EML5 SIPA1L1 TLN1 MARK4 ROCK1 DLEC1 TRAPPC14 SKA1 SNTA1 TBCEL MYBPC1	2.57e-04	1099	187	23	GO:0008092
GeneOntologyBiologicalProcess	protein localization to microtubule cytoskeleton	ABHD17A APC TTK C2CD3 ABHD17B MARK4	1.33e-05	59	182	6	GO:0072698
GeneOntologyBiologicalProcess	protein localization to cytoskeleton	ABHD17A APC TTK C2CD3 ABHD17B MARK4	1.95e-05	63	182	6	GO:0044380
GeneOntologyCellularComponent	site of DNA damage	ELOA2 ERCC6 ATR RBBP8 SMCHD1 TOPBP1 XRCC5 RIF1 POLQ	4.23e-06	137	188	9	GO:0090734
GeneOntologyCellularComponent	platelet dense tubular network membrane	ATP2A1 ATP2A2 ATP2A3	5.78e-05	9	188	3	GO:0031095
GeneOntologyCellularComponent	platelet dense tubular network	ATP2A1 ATP2A2 ATP2A3	1.12e-04	11	188	3	GO:0031094
GeneOntologyCellularComponent	dendrite	ABHD17A HTR4 EPHA6 KIF1B DOCK10 APC CHRM5 MAPK8IP3 TTLL7 NF1 ABHD17B SIPA1L1 MARK4 CNTNAP2 TRPM1 ALCAM DAGLA GABBR1 EPHB1	2.80e-04	858	188	19	GO:0030425
GeneOntologyCellularComponent	dendritic tree	ABHD17A HTR4 EPHA6 KIF1B DOCK10 APC CHRM5 MAPK8IP3 TTLL7 NF1 ABHD17B SIPA1L1 MARK4 CNTNAP2 TRPM1 ALCAM DAGLA GABBR1 EPHB1	2.88e-04	860	188	19	GO:0097447
GeneOntologyCellularComponent	leading edge membrane	MYO1G APC MAPK8IP3 TLN1 CNTNAP2 PLCG1 DAGLA GABBR1	6.46e-04	210	188	8	GO:0031256
MousePheno	abnormal B cell differentiation	RAG1 TRAF2 CCR9 BACH2 DOCK10 TSHR XRCC5 CR2 SESN1 RGS13 RIF1 ERCC6L2 POLQ	1.40e-05	287	151	13	MP:0002144
MousePheno	abnormal class switch recombination	RAG1 BACH2 XRCC5 CR2 SESN1 RIF1 ERCC6L2	2.66e-05	81	151	7	MP:0004816
MousePheno	abnormal midgut morphology	RUNX1T1 DNAH5 FOXF1	4.19e-05	7	151	3	MP:0009705
Domain	P-type_ATPase_IIA	ATP2A1 ATP2A2 ATP2A3	9.56e-07	3	185	3	IPR005782
Domain	SAXO1/2	SAXO2 SAXO1	9.76e-05	2	185	2	IPR033336
Domain	Hydrolase_3	ATP2A1 ATP2A2 ATP2A3	1.09e-04	10	185	3	PF08282
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	EPRS1 TRAF2 ERCC6 GATAD2A GNE MYO19 SMCHD1 DOCK10 NARS1 SHMT2 SRCAP XRCC5 USP14 RIF1 METTL13 NF1 PSME4 UBR5 PI4KA TLN1 EIF3L RNF20 ASPM ANKRD17 PLCG1 MTREX MGA ATP2A2	1.51e-09	1353	190	28	29467282
Pubmed	The effects of the phenylalanine 256 to valine mutation on the sensitivity of sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA) Ca2+ pump isoforms 1, 2, and 3 to thapsigargin and other inhibitors.	ATP2A1 ATP2A2 ATP2A3	1.60e-07	3	190	3	16410239
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	TRAF2 ERCC6 DCDC1 GATAD2A BACH2 MECOM KEAP1 SRCAP KANK2 DRG1 METTL13 EML5 ZFHX4 UBR5 ZNF592 SIPA1L1 TAF7L MARK4 ASPM ANKRD17 ZFHX3 MGA	2.30e-07	1116	190	22	31753913
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ZSWIM5 SPEG KIF1B DOCK10 DNAJC6 ZBED4 UBR5 SIPA1L1 RHOBTB2 TLN1 MARK4 PCDH10 USP33	4.37e-07	407	190	13	12693553
Pubmed	Expression of sarco (endo) plasmic reticulum calcium ATPase (SERCA) system in normal mouse cardiovascular tissues, heart failure and atherosclerosis.	ATP2A1 ATP2A2 ATP2A3	6.39e-07	4	190	3	25110346
Pubmed	The nongastric H+-K+-ATPases: molecular and functional properties.	ATP2A1 ATP2A2 ATP2A3	6.39e-07	4	190	3	10362770
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	RBBP8 BACH2 KIF1B TOPBP1 APC ZMYM2 MECOM SRCAP TTK UBR5 PI4KA ASPM ROCK1 DOT1L MTREX	9.62e-07	588	190	15	38580884
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	EPRS1 AMPD2 PSAP APC SHMT2 SRCAP ITGA9 TGIF1 EML5 PSME4 ABHD17B PI4KA SIPA1L1 VPS35L NFX1 ANKRD17 ROCK1 PLCG1 DOT1L MGA	2.31e-06	1084	190	20	11544199
Pubmed	Ebf factors and MyoD cooperate to regulate muscle relaxation via Atp2a1.	ATP2A1 ATP2A2 ATP2A3	5.53e-06	7	190	3	24786561
Pubmed	Widespread control of calcium signaling by a family of SERCA-inhibiting micropeptides.	ATP2A1 ATP2A2 ATP2A3	8.81e-06	8	190	3	27923914
Pubmed	Gene knockout studies of Ca2+-transporting ATPases.	ATP2A1 ATP2A2 ATP2A3	8.81e-06	8	190	3	10951186
Pubmed	Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death.	ATP2A1 ATP2A2 ATP2A3	8.81e-06	8	190	3	19033399
Pubmed	A micropeptide encoded by a putative long noncoding RNA regulates muscle performance.	ATP2A1 ATP2A2 ATP2A3	1.32e-05	9	190	3	25640239
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	AMPD2 GATAD2A BACH2 APC SHMT2 MECOM PFKFB3 ZFHX4 ROCK1 DOT1L MGA	1.34e-05	398	190	11	35016035
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	EPRS1 ATR SMCHD1 XRCC5 PI4KA CNTNAP2 ANKRD17 ATP2A2	1.66e-05	202	190	8	33005030
Pubmed	Progesterone induced Warburg effect in HEK293 cells is associated with post-translational modifications and proteasomal degradation of progesterone receptor membrane component 1.	ATR STYXL2 UBR5 PI4KA RNF20	1.67e-05	58	190	5	31067491
Pubmed	Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.	DOCK10 SIPA1L1 TLN1 ANKRD17 TRPM1 POLQ DNAH5 ATP2A2	2.05e-05	208	190	8	33230847
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	RBBP8 APC ZMYM2 MECOM KEAP1 ZFHX4 UBR5 ZNF592 ANKRD17 ZFHX3 MGA	2.11e-05	418	190	11	34709266
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	APC DNAJC6 MAPK8IP3 HSPA12A NF1 SIPA1L1 TRAPPC14 ATP2A2 SNTA1 GABBR1	2.34e-05	347	190	10	17114649
Pubmed	Functional proteomics mapping of a human signaling pathway.	ERCC6 PSAP TENT5A ZMYM2 KEAP1 METAP1 FBLN1 MAST4 UBR5 ZNF592 EIF3L ROCK1 MGA	2.48e-05	591	190	13	15231748
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	EPRS1 TRAF2 LARP6 PSAP KIF1B APC NARS1 ZMYM2 KANK2 MAPK8IP3 METAP1 P4HTM ZNF592 SIPA1L1 VPS35L ZNF624 PLCG1 ATP2A2 SNTA1 USP33	2.75e-05	1285	190	20	35914814
Pubmed	Ecotopic viral integration site 1 (EVI1) transcriptionally targets talin1 (TLN1) and upregulates its expression in chronic myeloid leukemia.	MECOM TLN1	2.97e-05	2	190	2	29214881
Pubmed	Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells.	RAG1 CR2	2.97e-05	2	190	2	17660822
Pubmed	IL-7-primed bystander CD8 tumor-infiltrating lymphocytes optimize the antitumor efficacy of T cell engager immunotherapy.	RAG1 CD274	2.97e-05	2	190	2	38744277
Pubmed	Deubiquitinase USP33 promotes the glycolysis and growth of osteosarcoma by modifying PFKFB3 ubiquitination and degradation.	PFKFB3 USP33	2.97e-05	2	190	2	37034227
Pubmed	Dietary calcium and cholecalciferol modulate cyclin D1 expression, apoptosis, and tumorigenesis in intestine of adenomatous polyposis coli1638N/+ mice.	APC CCND1	2.97e-05	2	190	2	18716166
Pubmed	Unveiling the Roles of Low-Density Lipoprotein Receptor-Related Protein 6 in Intestinal Homeostasis, Regeneration and Oncogenesis.	APC LRP6	2.97e-05	2	190	2	34359960
Pubmed	Modulation of B-cell endoplasmic reticulum calcium homeostasis by Epstein-Barr virus latent membrane protein-1.	ATP2A2 ATP2A3	2.97e-05	2	190	2	19650915
Pubmed	An unbalanced PD-L1/CD86 ratio in CD14(++)CD16(+) monocytes is correlated with HCV viremia during chronic HCV infection.	CD86 CD274	2.97e-05	2	190	2	24531620
Pubmed	The mouse ZFH-4 protein contains four homeodomains and twenty-two zinc fingers.	ZFHX4 ZFHX3	2.97e-05	2	190	2	10873665
Pubmed	CtIP Mutations Cause Seckel and Jawad Syndromes.	ATR RBBP8	2.97e-05	2	190	2	21998596
Pubmed	Effect of chronic obstructive pulmonary disease on calcium pump ATPase expression in human diaphragm.	ATP2A1 ATP2A2	2.97e-05	2	190	2	15718407
Pubmed	TopBP1 assembles nuclear condensates to switch on ATR signaling.	ATR TOPBP1	2.97e-05	2	190	2	33503405
Pubmed	Ku80 deletion suppresses spontaneous tumors and induces a p53-mediated DNA damage response.	APC XRCC5	2.97e-05	2	190	2	19010925
Pubmed	Regulation of SERCA pumps expression in diabetes.	ATP2A2 ATP2A3	2.97e-05	2	190	2	25270119
Pubmed	YTHDF1 enhances stemness and chemoresistance in triple-negative breast cancer cells by upregulating SIAH2.	SHMT2 YTHDF1	2.97e-05	2	190	2	37983722
Pubmed	Selective activation of N-acyl-D-glucosamine 2-epimerase expression in failing human heart ventricular myocytes.	GNE RENBP	2.97e-05	2	190	2	12612874
Pubmed	Training induced decrease in oxygen cost of cycling is accompanied by down-regulation of SERCA expression in human vastus lateralis muscle.	ATP2A1 ATP2A2	2.97e-05	2	190	2	18953100
Pubmed	SERCA overexpression reduces hydroxyl radical injury in murine myocardium.	ATP2A1 ATP2A2	2.97e-05	2	190	2	16798816
Pubmed	N6-methyladenosine reader YTHDF1 regulates the proliferation and migration of airway smooth muscle cells through m6A/cyclin D1 in asthma.	CCND1 YTHDF1	2.97e-05	2	190	2	36992945
Pubmed	Mechanisms of control of the free Ca2+ concentration in the endoplasmic reticulum of mouse pancreatic β-cells: interplay with cell metabolism and [Ca2+]c and role of SERCA2b and SERCA3.	ATP2A2 ATP2A3	2.97e-05	2	190	2	21885870
Pubmed	The transcription factor BACH2 promotes tumor immunosuppression.	RAG1 BACH2	2.97e-05	2	190	2	26731475
Pubmed	Human FAM154A (SAXO1) is a microtubule-stabilizing protein specific to cilia and related structures.	SAXO2 SAXO1	2.97e-05	2	190	2	25673876
Pubmed	CD86 is expressed on murine hematopoietic stem cells and denotes lymphopoietic potential.	RAG1 CD86	2.97e-05	2	190	2	22371880
Pubmed	Targeted disruption of the ATP2A1 gene encoding the sarco(endo)plasmic reticulum Ca2+ ATPase isoform 1 (SERCA1) impairs diaphragm function and is lethal in neonatal mice.	ATP2A1 ATP2A2	2.97e-05	2	190	2	12556521
Pubmed	Oral interleukin-10 alleviates polyposis via neutralization of pathogenic T-regulatory cells.	RAG1 APC	2.97e-05	2	190	2	25228656
Pubmed	Atypical fast SERCA1a protein expression in slow myofibers and differential S-nitrosylation prevented by exercise during long term bed rest.	ATP2A1 ATP2A2	2.97e-05	2	190	2	19644701
Pubmed	Pathogenic natural antibodies recognizing annexin IV are required to develop intestinal ischemia-reperfusion injury.	RAG1 CR2	2.97e-05	2	190	2	19380783
Pubmed	Sarco(endo)plasmic reticulum Ca2+ ATPases (SERCA1 and -2) in human extraocular muscles.	ATP2A1 ATP2A2	2.97e-05	2	190	2	14638697
Pubmed	High levels of TopBP1 induce ATR-dependent shut-down of rRNA transcription and nucleolar segregation.	ATR TOPBP1	2.97e-05	2	190	2	25916852
Pubmed	Adenovirus 12 E4orf6 inhibits ATR activation by promoting TOPBP1 degradation.	ATR TOPBP1	2.97e-05	2	190	2	20566845
Pubmed	Multiple and diverse coexpression, location, and regulation of additional SERCA2 and SERCA3 isoforms in nonfailing and failing human heart.	ATP2A2 ATP2A3	2.97e-05	2	190	2	19962989
Pubmed	Multiple Routes to Oncogenesis Are Promoted by the Human Papillomavirus-Host Protein Network.	KEAP1 RNF20	2.97e-05	2	190	2	30209081
Pubmed	Expression of ALCAM (CD166) and PD-L1 (CD274) independently predicts shorter survival in malignant pleural mesothelioma.	CD274 ALCAM	2.97e-05	2	190	2	28811252
Pubmed	The adaptor protein alpha-syntrophin is reduced in human non-alcoholic steatohepatitis but is unchanged in hepatocellular carcinoma.	SCARB1 SNTA1	2.97e-05	2	190	2	28941732
Pubmed	A bifunctional enzyme catalyzes the first two steps in N-acetylneuraminic acid biosynthesis of rat liver. Molecular cloning and functional expression of UDP-N-acetyl-glucosamine 2-epimerase/N-acetylmannosamine kinase.	GNE RENBP	2.97e-05	2	190	2	9305888
Pubmed	SERCA1 truncated proteins unable to pump calcium reduce the endoplasmic reticulum calcium concentration and induce apoptosis.	ATP2A1 ATP2A2	2.97e-05	2	190	2	11402072
Pubmed	Cyclin D1 down-regulation is essential for DBC2's tumor suppressor function.	CCND1 RHOBTB2	2.97e-05	2	190	2	17517369
Pubmed	TopBP1 and ATR colocalization at meiotic chromosomes: role of TopBP1/Cut5 in the meiotic recombination checkpoint.	ATR TOPBP1	2.97e-05	2	190	2	14718568
Pubmed	High PD-L1/CD86 ratio on plasmacytoid dendritic cells correlates with elevated T-regulatory cells in liver transplant tolerance.	CD86 CD274	2.97e-05	2	190	2	18301333
Pubmed	Mutant APC promotes tumor immune evasion via PD-L1 in colorectal cancer.	APC CD274	2.97e-05	2	190	2	34385594
Pubmed	PD-L1 upregulation accompanied with epithelial-mesenchymal transition attenuates sensitivity to ATR inhibition in p53 mutant pancreatic cancer cells.	ATR CD274	2.97e-05	2	190	2	32277292
Pubmed	Sarco(endo)plasmic reticulum Ca2+ ATPase isoforms and their role in muscle physiology and pathology.	ATP2A1 ATP2A2	2.97e-05	2	190	2	10603953
Pubmed	Characterizing SERCA Function in Murine Skeletal Muscles after 35-37 Days of Spaceflight.	ATP2A1 ATP2A2	2.97e-05	2	190	2	34769190
Pubmed	Deletion of Ku80 causes early aging independent of chronic inflammation and Rag-1-induced DSBs.	RAG1 XRCC5	2.97e-05	2	190	2	17928034
Pubmed	Alterations in genes encoding sarcoplasmic-endoplasmic reticulum Ca(2+) pumps in association with head and neck squamous cell carcinoma.	ATP2A2 ATP2A3	2.97e-05	2	190	2	18295663
Pubmed	KIF1B and NF1 are the most frequently mutated genes in paraganglioma and pheochromocytoma tumors.	KIF1B NF1	2.97e-05	2	190	2	28515046
Pubmed	SPEG Controls Calcium Reuptake Into the Sarcoplasmic Reticulum Through Regulating SERCA2a by Its Second Kinase-Domain.	SPEG ATP2A2	2.97e-05	2	190	2	30566039
Pubmed	Dissection of the functional differences between sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) 1 and 2 isoforms and characterization of Darier disease (SERCA2) mutants by steady-state and transient kinetic analyses.	ATP2A1 ATP2A2	2.97e-05	2	190	2	12975374
Pubmed	Activation of DSB processing requires phosphorylation of CtIP by ATR.	ATR RBBP8	2.97e-05	2	190	2	23273981
Pubmed	Genome-wide CRISPR screens using isogenic cells reveal vulnerabilities conferred by loss of tumor suppressors.	GATAD2A SMCHD1 TOPBP1 KEAP1 MAPK8IP3 USP14 NF1 RNF20 POLQ MGA	3.12e-05	359	190	10	35559673
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SPEG SRCAP ADCY7 MAPK8IP3 C2CD3 KLHL25 PSME4 ZBED4 ZNF592 PI4KA SCARB1 TLN1 MARK4 NFX1 PLCG1 DENND5A DOT1L ATP2A3	3.95e-05	1105	190	18	35748872
Pubmed	A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility.	RAG1 ERCC6 ATR CCND1	4.95e-05	37	190	4	19116388
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	SMCHD1 TOPBP1 MECOM KEAP1 SRCAP KANK2 C2CD3 ZNF592 PI4KA TLN1 RNF20 ROCK1 SKA1	6.06e-05	645	190	13	25281560
Pubmed	HORMAD1-dependent checkpoint/surveillance mechanism eliminates asynaptic oocytes.	ATR TEX11 TAF7L	6.96e-05	15	190	3	22530760
Pubmed	Overlapping Activities of Two Neuronal Splicing Factors Switch the GABA Effect from Excitatory to Inhibitory by Regulating REST.	EPRS1 CACNA2D2 KIF1B DOCK10 ATP2A2 GABBR1	7.67e-05	128	190	6	30995482
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	BACH2 KIF1B APC SHMT2 KANK2 TTK AP4E1 C2CD3 CEP120 MAST4 UBR5 SIPA1L1 TLN1 NFX1 MGA	7.68e-05	853	190	15	28718761
Pubmed	Prediction of the coding sequences of unidentified human genes. II. The coding sequences of 40 new genes (KIAA0041-KIAA0080) deduced by analysis of cDNA clones from human cell line KG-1.	KIF1B PPWD1 PSME4 MTREX	8.21e-05	42	190	4	7584044
Pubmed	Primary Autosomal Recessive Microcephalies and Seckel Syndrome Spectrum Disorders – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY	ATR RBBP8 ASPM	8.53e-05	16	190	3	20301772
Pubmed	Aurora B opposes PP1 function in mitosis by phosphorylating the conserved PP1-binding RVxF motif in PP1 regulatory proteins.	RIF1 UBR5 ASPM	8.53e-05	16	190	3	29764992
Pubmed	Neuroblast differentiation during development and in neuroblastoma requires KIF1Bβ-mediated transport of TRKA.	KIF1B CCND1 NF1	8.53e-05	16	190	3	28637693
Pubmed	Degree and site of chromosomal instability define its oncogenic potential.	APC TTK	8.87e-05	3	190	2	32198375
Pubmed	Post-endocytotic Deubiquitination and Degradation of the Metabotropic γ-Aminobutyric Acid Receptor by the Ubiquitin-specific Protease 14.	USP14 GABBR1	8.87e-05	3	190	2	26817839
Pubmed	Calpain 3 deficiency affects SERCA expression and function in the skeletal muscle.	ATP2A1 ATP2A2	8.87e-05	3	190	2	27055500
Pubmed	NFE2L2/KEAP1 Mutations Correlate with Higher Tumor Mutational Burden Value/PD-L1 Expression and Potentiate Improved Clinical Outcome with Immunotherapy.	KEAP1 CD274	8.87e-05	3	190	2	32272498
Pubmed	Modulation of endoplasmic reticulum calcium pump by Bcl-2.	ATP2A2 ATP2A3	8.87e-05	3	190	2	9788433
Pubmed	Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy.	APC CCND1	8.87e-05	3	190	2	16322291
Pubmed	Human platelet Ca2+-ATPases: new markers of cell differentiation as illustrated in idiopathic scoliosis.	ATP2A2 ATP2A3	8.87e-05	3	190	2	16973504
Pubmed	Cyclin D1 is not an essential target of beta-catenin signaling during intestinal tumorigenesis, but it may act as a modifier of disease severity in multiple intestinal neoplasia (Min) mice.	APC CCND1	8.87e-05	3	190	2	12183406
Pubmed	Nrf2 activation does not affect adenoma development in a mouse model of colorectal cancer.	APC KEAP1	8.87e-05	3	190	2	34526660
Pubmed	The Heteromeric Complex Formed by Dopamine Receptor D5 and CCR9 Leads the Gut Homing of CD4+ T Cells Upon Inflammation.	RAG1 CCR9	8.87e-05	3	190	2	33864900
Pubmed	The transcription factor XBP-1 is essential for the development and survival of dendritic cells.	RAG1 CEP120	8.87e-05	3	190	2	17875675
Pubmed	Coordinated nuclease activities counteract Ku at single-ended DNA double-strand breaks.	RBBP8 XRCC5	8.87e-05	3	190	2	27641979
Pubmed	Plasmacytoid dendritic cells transport peripheral antigens to the thymus to promote central tolerance.	RAG1 CCR9	8.87e-05	3	190	2	22444632
Pubmed	An essential function for the ATR-activation-domain (AAD) of TopBP1 in mouse development and cellular senescence.	ATR TOPBP1	8.87e-05	3	190	2	23950734
Pubmed	TLR3-stimulated dendritic cells up-regulate B7-H1 expression and influence the magnitude of CD8 T cell responses to tumor vaccination.	CD86 CD274	8.87e-05	3	190	2	19710456
Pubmed	RBMX is required for activation of ATR on repetitive DNAs to maintain genome stability.	ATR TOPBP1	8.87e-05	3	190	2	32494026
Pubmed	Retinoic acid determines the precise tissue tropism of inflammatory Th17 cells in the intestine.	RAG1 CCR9	8.87e-05	3	190	2	20400707
Pubmed	Cyclin D1 is not an immediate target of beta-catenin following Apc loss in the intestine.	APC CCND1	8.87e-05	3	190	2	15946945
Pubmed	Presynaptic α2δ subunits are key organizers of glutamatergic synapses.	CACNA2D2 CACNA2D3	8.87e-05	3	190	2	33782113
Cytoband	3p21.3	CACNA2D2 CCR9 ITGA9 P4HTM DLEC1	4.81e-06	59	190	5	3p21.3
Cytoband	16p12.3	TMC7 ACSM1 VPS35L ACSM5	1.20e-05	34	190	4	16p12.3
GeneFamily	ATPases Ca2+ transporting	ATP2A1 ATP2A2 ATP2A3	3.61e-05	9	139	3	1209
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	B3GALNT1 EPRS1 ATR RBBP8 TENT5A SMCHD1 DOCK10 APC NARS1 ELSPBP1 PPWD1 TTK TTLL7 RIF1 RNF20 ASPM TRPM1 MTREX POLQ RNF145	5.55e-08	656	187	20	M18979
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	ATR GNE SMCHD1 TOPBP1 APC ZMYM2 MECOM CCND1 TTK TGIF1 RIF1 C2CD3 PSME4 UBR5 SIPA1L1 ANKRD17 ROCK1 ZFHX3 ALCAM DENND5A MTREX	9.18e-07	856	187	21	M4500
Coexpression	GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_UP	CCR9 KIF1B APC SESN1 ADCY7 MAPK8IP3 EML5 LRP6	1.41e-05	152	187	8	M2938
Coexpression	GSE23984_CTRL_VS_HYPOCALEMIC_VITAMIND_ANALOG_TCELL_DN	B3GALNT1 NARS1 CCND1 ITGA9 SESN1 VWA5A ALCAM MCOLN3 USP33	1.44e-05	200	187	9	M8052
Coexpression	ROSS_ACUTE_MYELOID_LEUKEMIA_CBF	CACNA2D2 RUNX1T1 ADCY7 PI4KA SIPA1L1 CD58	2.72e-05	82	187	6	M7804
Coexpression	MULLIGHAN_MLL_SIGNATURE_2_DN	RUNX1T1 TEX11 SESN1 STAP1 METAP1 MAST4 UBR5 SIPA1L1 ATP2A2 ATP2A3	3.43e-05	279	187	10	M16867
Coexpression	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP	B3GALNT1 EPRS1 LARP6 SMCHD1 ZMYM2 ELSPBP1 RIF1 PSME4 SLCO4C1 ASPM CD274 ALCAM	3.61e-05	404	187	12	M19488
Coexpression	GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_UP	BACH2 SESN1 GABBR1	4.13e-05	10	187	3	M13976
Coexpression	MURARO_PANCREAS_BETA_CELL	EPRS1 C2orf69 AMPD2 PSAP RBBP8 SPEG DOCK10 APC RUNX1T1 DNAJC6 SESN1 TTLL7 MAST4 PI4KA RASD1 ROCK1 ALCAM DNAH5 ATP2A3	5.05e-05	946	187	19	M39169
Coexpression	HE_LIM_SUN_FETAL_LUNG_C3_OMD_POS_ENDOTHELIAL_CELL	CALHM5 GARNL3 SPEG TENT5A MECOM RUNX1T1 FBLN1 P4HTM CD58 ALCAM ATP2A3	5.25e-05	355	187	11	M45758
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_200	RUNX1T1 ZFHX4 ZFHX3 TRPM1 RXFP1 PCDH10	6.92e-06	54	183	6	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_200_k2
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	KLK15 GARNL3 ATR ZSWIM5 RBBP8 SMCHD1 BACH2 APC ZMYM2 PPWD1 TTK RIF1 CEP120 EML5 PSME4 ABHD17B ZBED4 RNF20 CNTNAP2 ASPM ZNF624 ROCK1 ZFHX3 TRPM1 MTREX TRAPPC14 SKA1 EFCAB7 ATP2A3	2.08e-05	1459	183	29	facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000	FAT4 LARP6 GATAD2A TENT5A BACH2 KIF1B APC RUNX1T1 DNAJC6 KANK2 MAPK8IP3 C2CD3 ZFHX4 SIPA1L1 ERCC6L2 ZFHX3 RXFP1 PCDH10 FOXF1 EPHB1	2.76e-05	818	183	20	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	GARNL3 ATR ZSWIM5 RBBP8 SMCHD1 BACH2 APC ZMYM2 PPWD1 TTK RIF1 CEP120 EML5 PSME4 ABHD17B ZBED4 RNF20 CNTNAP2 ASPM ZNF624 ROCK1 ZFHX3 MTREX TRAPPC14 SKA1 EFCAB7	3.01e-05	1257	183	26	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#2_top-relative-expression-ranked_500	RUNX1T1 ZFHX4 ERCC6L2 ZFHX3 TRPM1 PCDH10	3.68e-05	72	183	6	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500_k2
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500	FAT4 TENT5A BACH2 APC SMOC1 RUNX1T1 C2CD3 ZFHX4 SIPA1L1 ERCC6L2 PCDH10 FOXF1 CACNA2D3	5.51e-05	407	183	13	gudmap_developingLowerUrinaryTract_e14.5_ urethra_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_500	LARP6 TENT5A BACH2 APC RUNX1T1 KANK2 MAPK8IP3 C2CD3 ZFHX4 ERCC6L2 RXFP1 PCDH10 FOXF1	6.88e-05	416	183	13	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_100	ZFHX4 RXFP1 PCDH10	7.23e-05	10	183	3	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_100_k4
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#3_top-relative-expression-ranked_1000	RUNX1T1 ZFHX4 ERCC6L2 ZFHX3 TRPM1 RXFP1 PCDH10	7.42e-05	118	183	7	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#1_top-relative-expression-ranked_1000	FAT4 RUNX1T1 ZFHX4 SIPA1L1 ZFHX3 RXFP1 PCDH10	8.25e-05	120	183	7	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k1
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#4_top-relative-expression-ranked_200	RUNX1T1 ZFHX4 ZFHX3 RXFP1 PCDH10	8.43e-05	52	183	5	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_200_k4
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_500	LARP6 TENT5A BACH2 APC KANK2 MAPK8IP3 C2CD3 ERCC6L2 FOXF1	8.66e-05	209	183	9	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k2
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_500	HTR4 BACH2 APC RUNX1T1 RIF1 ZFHX4 ERCC6L2 ZFHX3 TRPM1 RXFP1 PCDH10 CACNA2D3	1.52e-04	390	183	12	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3	EPRS1 ERCC6 RBBP8 MYO19 TTK FBXO30 RIF1 EML5 ZBED4 UBR5 ASPM ROCK1 POLQ SKA1	2.21e-04	532	183	14	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500	RUNX1T1 SRCAP FBXO30 RIF1 MAST4 ZFHX4 ASPM RBM46 ZFHX3 RNF145 MGA MYBPC1	2.35e-04	409	183	12	gudmap_developingGonad_e12.5_ovary_500
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500	KIF1B RUNX1T1 FBXO30 RIF1 MAST4 ZFHX4 ASPM ROCK1 ZFHX3 RNF145 MGA MYBPC1	2.80e-04	417	183	12	gudmap_developingGonad_e11.5_ovary + mesonephros_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#2_top-relative-expression-ranked_200	TENT5A ERCC6L2 RBM46 FOXF1 EPHB1	2.82e-04	67	183	5	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k2_200
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#5_top-relative-expression-ranked_100	TENT5A RBM46 FOXF1 EPHB1	3.13e-04	38	183	4	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k5_100
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HTR4 WNT11 RUNX1T1 ITGA9 KANK2 ADAMTS12 FBLN1 ZFHX4	1.01e-06	179	189	8	02c90d8306016365ed811f0c63cfb3ac7b85464c
ToppCell	LPS-antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TDRD5 HTR4 SPEG WNT11 ZFHX4 RAB40C DRC3	1.27e-06	128	189	7	2cf0384240a4a663869cf6b27d954236f6214a9a
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	FAT4 MECOM RUNX1T1 FBLN1 CEP120 CNTNAP2 ZFHX3 EPHB1	1.35e-06	186	189	8	7def03dd856b765bd3f493288641981c4f7fd26e
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO1G DOCK10 ITGA9 ADCY7 RGS13 CD86 SIPA1L1 ATP2A3	1.52e-06	189	189	8	7ccea2df93bb4b37417bbc8f6c85a61ece95211a
ToppCell	facs-Aorta-Heart-3m\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1G CCND1 ITGA9 RIF1 ZFHX3 ALCAM MTREX ENPEP	1.71e-06	192	189	8	1ccc47792edf9ee23501c8e2165d11271636b66a
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	FAT4 DOCK10 CCND1 RUNX1T1 ADAMTS12 FBLN1 MAST4 CNTNAP2	1.92e-06	195	189	8	1cdf5f296029ae424d9dba42e86a6d111e4896e6
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK10 RENBP ITGA9 ADCY7 RGS13 STAP1 VWA5A CD274	2.15e-06	198	189	8	cc5ca64749e2f4f1d373d9472824df85741702b7
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Mast_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK10 RENBP ITGA9 ADCY7 RGS13 STAP1 VWA5A CD274	2.15e-06	198	189	8	d4d66f19df078bfc3a83d4664aaf9c7789bde1a5
ToppCell	NS-moderate-d_07-13-Myeloid-Mast_cell\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CACNA2D2 TENT5A RGS13 STAP1 TTLL7 MAST4 VWA5A	4.74e-06	156	189	7	17c38d3b03fc38cb125cf0d165b2fd694cd88edd
ToppCell	control-Epithelial-Ionocyte\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	WNT11 SMOC1 RUNX1T1 STAP1 HSPA12A RASD1 ATP2A3	6.86e-06	165	189	7	5cfba9a46bd8ceeca74a6493057b4d38af6b06fe
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MECOM SMOC1 METTL13 MAST4 ZSWIM4 FOXF1 EPHB1	6.86e-06	165	189	7	62457b7b74c6eae42d91d65e7dc6df6bf8e061f7
ToppCell	moderate-Myeloid-Mast_cell\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CACNA2D2 TENT5A RGS13 STAP1 TTLL7 MAST4 VWA5A	7.13e-06	166	189	7	c3835b424c63bf11a4e2c47635dc3787fc4a637a
ToppCell	facs-Lung-EPCAM-3m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BACH2 CR2 PPWD1 SESN1 STAP1 CD86 GPR171	7.71e-06	168	189	7	784ce773521e5d74570f45120e56d112bc76ff49
ToppCell	facs-Lung-EPCAM-3m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BACH2 CR2 PPWD1 SESN1 STAP1 CD86 GPR171	8.33e-06	170	189	7	7a4ed69c807c3761210776e8fe6680d1bd892e82
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Chat_Htr1f\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	FAT4 HTR4 TENT5A TSHR RASD1 ALCAM RXFP1	8.66e-06	171	189	7	f9ae7964a3740f559431125c17c660549798cccc
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Mast_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO1G DOCK10 ITGA9 ADCY7 RGS13 ABHD17B ATP2A3	8.99e-06	172	189	7	cc9d9dae290f11f8c348c78228af4e49469dc93b
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO1G DOCK10 ITGA9 ADCY7 RGS13 ABHD17B ATP2A3	8.99e-06	172	189	7	3a37569a5902f3c65ff8d3912421309a8c82ee9b
ToppCell	PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	B3GALNT1 C2orf69 TTK SESN1 METTL13 ASPM SNTA1	9.34e-06	173	189	7	12c6875f881cb0fbff09d753b53c1cce7a95527f
ToppCell	facs-Liver-Non-hepatocytes-3m-Lymphocytic-B_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BACH2 ITPRID1 CR2 SESN1 MAST4 GPR171 MCOLN3	9.70e-06	174	189	7	8bdf5a97faf1cf0426d1a8851f8a3e27578f7598
ToppCell	facs-Liver-Non-hepatocytes-3m-Lymphocytic-B_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BACH2 ITPRID1 CR2 SESN1 MAST4 GPR171 MCOLN3	9.70e-06	174	189	7	fbf998dd33ac27dad7639ea85fca393ba2835307
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Chat_Htr1f\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	HTR4 TENT5A DOCK10 TSHR PFKFB3 SMOC1 ALCAM	9.70e-06	174	189	7	a5f2a4e3b25e6084bd7003a53da86a44f6fcf294
ToppCell	moderate-Myeloid-Mast_cell\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CACNA2D2 TENT5A RGS13 STAP1 TTLL7 MAST4 VWA5A	1.01e-05	175	189	7	bbd2971bc6d69e507f90a637834d0936c205c590
ToppCell	NS-moderate-d_0-4-Epithelial-Ionocyte\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CACNA2D2 WNT11 SMOC1 RUNX1T1 STAP1 RASD1 TMEM262	1.01e-05	175	189	7	a1e0a15c69211d6db2edeb101476f0f6e08b90c8
ToppCell	facs-GAT-Fat-3m-Lymphocytic-B_cell\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BACH2 TEX11 CR2 STAP1 TGIF1 GPR171 ATP2A3	1.12e-05	178	189	7	5b6f7e8a930c239db1f31edfb61b2b9228d28663
ToppCell	droplet-Marrow-nan-18m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	B3GALNT1 PSAP CCR9 CCND1 ABHD17B GPR171 ATP2A1	1.17e-05	179	189	7	1757b9f3f4c634277a67c4f5a39d27d6b4937073
ToppCell	facs-MAT-Fat-24m-Lymphocytic-B_cell\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RGS13 STAP1 TGIF1 ABHD17B CD86 GPR171 ATP2A3	1.21e-05	180	189	7	711719219bcbafdd505790eda895e7a33f21bed2
ToppCell	droplet-Lung-LUNG-30m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAG1 SMCHD1 BACH2 CR2 SESN1 ABHD17B GPR171	1.25e-05	181	189	7	ce0e39114bf3bcbcce0fd4c0d70bedadd0853e1d
ToppCell	Immune_cells-Dendritic_cells\|Immune_cells / Lineage and Cell class	B3GALNT1 PSAP CCR9 CCND1 ABHD17B GPR171 ATP2A1	1.30e-05	182	189	7	99c7d4f1e7cd745643ba64b59190113bcd4e348e
ToppCell	droplet-Kidney-nan-21m-Epithelial-Epcam____podocyte-2\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANGPT2 HTR4 WNT11 ITPRID1 HSPA12A SERPINA10 TRPM1	1.35e-05	183	189	7	877559962b2b073fc2a9f1b64a76e17895e40a97
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HTR4 WNT11 RUNX1T1 ITGA9 ADAMTS12 FBLN1 ZFHX4	1.35e-05	183	189	7	12daaea821e49bc94a01e2496331e92a80d27339
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-brain_pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CALHM5 GPR21 SPEG KANK2 ZFHX3 ATP2A3 ENPEP	1.39e-05	184	189	7	89ae8bf1a6c2d355d279d23a5e24a08d9ec2334e
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-Pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CALHM5 GPR21 SPEG KANK2 ZFHX3 ATP2A3 ENPEP	1.39e-05	184	189	7	34c84ac9a32eaf96f45b79485119cad65905817d
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	RBBP8 MECOM CCND1 ITGA9 MAST4 RNF145 DNAH5	1.39e-05	184	189	7	102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7
ToppCell	TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-4\|TCGA-Thryoid / Sample_Type by Project: Shred V9	PSAP GATAD2A RBBP8 P2RY2 VWA5A DAGLA MCOLN3	1.39e-05	184	189	7	d9659d1e4465fec68f48a22edef443f354f6c7cf
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HTR4 DOCK10 RUNX1T1 ITGA9 ADAMTS12 FBLN1 ZFHX4	1.44e-05	185	189	7	3b2dfc8f4c87be516265dbecfc251276034d0efd
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	TENT5A ITGA9 RGS13 TTLL7 VWA5A CD274 ATP2A3	1.49e-05	186	189	7	de55471dd5c842026b409cfebf67fe32f079a011
ToppCell	facs-SCAT-Fat-3m-Lymphocytic-B_cell\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BACH2 CR2 SESN1 STAP1 TGIF1 GPR171 ATP2A3	1.49e-05	186	189	7	d5d990d8b6ccd8ca8fe7d0d7dedbe2359ae7b582
ToppCell	facs-Lung-3m-Hematologic-lymphocytic-B_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BACH2 CR2 SESN1 RGS13 STAP1 CD86 GPR171	1.55e-05	187	189	7	57f9c9162694c184a8fd6634ee0fad511ca71c9e
ToppCell	facs-Lung-3m-Hematologic-lymphocytic-B_cell-B_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BACH2 CR2 SESN1 RGS13 STAP1 CD86 GPR171	1.55e-05	187	189	7	6ce6d3678026101c4397320430433c9f05740883
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CACNA2D2 MECOM MAST4 SLCO4C1 RHOBTB2 RAB40C ALCAM	1.55e-05	187	189	7	5df9e1f5ca32217af255e76e6fb5afa346337811
ToppCell	(04)_Pre-ciliated-(3)_72hpi\|(04)_Pre-ciliated / shred by cell type and Timepoint	SAXO2 CFAP65 VPS13D CEP120 DLEC1 DNAH5 DRC3	1.60e-05	188	189	7	f911dc61b008b60aaa2a1e9354085f480a669e2c
ToppCell	ASK428-Endothelial-Lymphatic\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	FAT4 ANGPT2 CCND1 RUNX1T1 KLHL25 VPS35L CCDC136	1.60e-05	188	189	7	c371bc340966cfe9205cbf4b62c6452f49f2559f
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	SPEG WNT11 ITGA9 FBLN1 CEP120 ZFHX3 FOXF1	1.60e-05	188	189	7	3004e961d214919e08c7cd5f10c3de5cf85b35a3
ToppCell	facs-MAT-Fat-3m-Lymphocytic-B_cell\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BACH2 CR2 SESN1 STAP1 TGIF1 GPR171 ATP2A3	1.60e-05	188	189	7	a7158b5c94e6b356877f016e52f2c24a3f5d24d2
ToppCell	ASK454-Endothelial-Lymphatic\|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq	ELOA2 ANGPT2 CEP120 VPS35L RNF20 CD274 PLCG1	1.66e-05	189	189	7	316c857dec9383823e09f966bca62d52d933b141
ToppCell	metastatic_Lymph_Node-Myeloid_cells-Undetermined\|Myeloid_cells / Location, Cell class and cell subclass	LARP6 ELSPBP1 RGS13 TTLL7 S100A3 MAST4 VWA5A	1.66e-05	189	189	7	b46adb47768a7b6d801c457d7ba65508edfc36a5
ToppCell	distal-Hematologic-Basophil/Mast_2-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	WNT11 RENBP CR2 RGS13 STAP1 ABHD17B VWA5A	1.90e-05	193	189	7	f22d0a2ea6bbdd625909ccb6a89aca89ab670306
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	B3GALNT1 AMPD2 PSAP KIF1B EML5 ATP2A2 ATP2A3	1.90e-05	193	189	7	471e65f02937bc18d7c5facdacdf1df58cf0f839
ToppCell	distal-Hematologic-Basophil/Mast_2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	WNT11 RENBP CR2 RGS13 STAP1 ABHD17B VWA5A	1.90e-05	193	189	7	dcdc1498726c68bf590bf84cb81e5f7fb7ba4d78
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	B3GALNT1 AMPD2 PSAP KIF1B EML5 ATP2A2 ATP2A3	1.90e-05	193	189	7	fe451b3295d77b2bd1ac25cf29310c85835a45fe
ToppCell	droplet-Pancreas-Endocrine-21m\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	B3GALNT1 AMPD2 PSAP KIF1B EML5 ATP2A2 ATP2A3	1.96e-05	194	189	7	3a3ecedcdc7691cf21775818b598208fcb980c29
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-Secretory/RAS-RAS\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	OR5T3 MECOM CCND1 ITGA9 MAST4 RASD1 RNF145	1.96e-05	194	189	7	a58841b34efe673671a9a059238e044a7254b279
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TENT5A WNT11 RUNX1T1 ADAMTS12 FBLN1 ZFHX4 CEACAM18	1.96e-05	194	189	7	c49f72441b3557e2c3a9c4239e68c0cf0652814b
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-Secretory/RAS\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	OR5T3 MECOM CCND1 ITGA9 MAST4 RASD1 RNF145	1.96e-05	194	189	7	0cd4363627acd419e00d6d32f6dce10430aa6487
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	B3GALNT1 AMPD2 PSAP KIF1B EML5 ATP2A2 ATP2A3	1.96e-05	194	189	7	0b023de48ed8a550d169bbe954881eb04bf4f981
ToppCell	3'-Broncho-tracheal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TENT5A RENBP ELSPBP1 RGS13 STAP1 TTLL7 VWA5A	1.96e-05	194	189	7	9d7f232ef5f27c28f325edfa6614f479013acbba
ToppCell	COVID-19-kidney-Proliferating_T_cell\|kidney / Disease (COVID-19 only), tissue and cell type	MYO1G DOCK10 TTK ASPM GPR171 POLQ SKA1	2.03e-05	195	189	7	7e05e56f8d0a7a052830c7db12b10dace7d10760
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PSAP KIF1B TTLL7 RIF1 MGA ATP2A2 ATP2A3	2.03e-05	195	189	7	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	distal-2-Endothelial-Lymphatic\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ANGPT2 SMOC1 ABHD17B ZFHX4 VPS35L ACSM5 EPHB1	2.03e-05	195	189	7	8e0f67a67af3bc0b16f48a621f74540f136383b7
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PSAP KIF1B TTLL7 RIF1 MGA ATP2A2 ATP2A3	2.03e-05	195	189	7	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	E18.5-samps-Mesenchymal-Matrix_fibroblast-matrix_-_mature_2\|E18.5-samps / Age Group, Lineage, Cell class and subclass	CALHM5 LARP6 WNT11 HSPA12A JRK DRC3	2.05e-05	131	189	6	f2eee150f5cff852e8f52f09b35e26f17d80833b
ToppCell	11.5-Distal-Mesenchymal-Airway_Smooth_Muscle\|Distal / Age, Tissue, Lineage and Cell class	SPEG WNT11 ITGA9 FBLN1 CEP120 ZFHX3 FOXF1	2.09e-05	196	189	7	05530fe7a5681c2f39b95016cd22ef99d6ac0430
ToppCell	wk_20-22-Epithelial\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	SAXO2 CFAP65 P4HTM DLEC1 ALCAM DNAH5 DRC3	2.16e-05	197	189	7	468071c1911cdf8e8806a78dbceb95379e28ae91
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	DOCK10 CCND1 RUNX1T1 ADAMTS12 FBLN1 MAST4 CNTNAP2	2.16e-05	197	189	7	31a1852911bda38543916585fda34255fd62a134
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DCDC1 SAXO2 CFAP65 HSPA12A DLEC1 DNAH5 DRC3	2.16e-05	197	189	7	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	PCW_13-14-Mesenchymal\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	FAT4 DOCK10 RUNX1T1 KANK2 ADAMTS12 FBLN1 CNTNAP2	2.16e-05	197	189	7	73a2085d2682d636726a5432d572ae2a3fbe1c3f
ToppCell	facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CALHM5 LARP6 MECOM SMOC1 FBLN1 ZFHX4 ATP2A3	2.16e-05	197	189	7	3fe665c0277d091290b63f0dd24c0c6536a45309
ToppCell	medial-2-Endothelial-Lymphatic\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ANGPT2 SMOC1 ITGA9 ABHD17B VPS35L ACSM5 EPHB1	2.24e-05	198	189	7	e4274584512a72270087a1ab104fab449a2f83bc
ToppCell	LPS_only-Epithelial_airway-airway_epithelial-Ciliated\|LPS_only / Treatment groups by lineage, cell group, cell type	SAXO2 CFAP65 P4HTM EML5 DLEC1 DNAH5 DRC3	2.24e-05	198	189	7	6d90b541fde357fbb40f8f7d4e8628a48b679718
ToppCell	10x5'v1-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	ANGPT2 RENBP RGS13 STAP1 TTLL7 MAST4 VWA5A	2.24e-05	198	189	7	a1247a5efd92f95c6227c0e71dc8a0427eb54b7f
ToppCell	medial-Endothelial-Lymphatic-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ANGPT2 SMOC1 ITGA9 ABHD17B VPS35L ACSM5 EPHB1	2.24e-05	198	189	7	41983d405215b974044e2e9e6c212b134336a6fe
ToppCell	medial-Endothelial-Lymphatic\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ANGPT2 SMOC1 ITGA9 ABHD17B VPS35L ACSM5 EPHB1	2.24e-05	198	189	7	1760fede363544bc0fa2e22fe36aff522abd2525
ToppCell	11.5-Airway-Mesenchymal-Airway_Smooth_Muscle\|Airway / Age, Tissue, Lineage and Cell class	SPEG WNT11 ITGA9 FBLN1 CEP120 ZFHX3 FOXF1	2.31e-05	199	189	7	1a8c77d241bd817a195e1532fd25f51358cb1ff1
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Mast_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK10 RENBP ITGA9 RGS13 STAP1 VWA5A ATP2A3	2.38e-05	200	189	7	9156f8fd61a833891d2f7b7fadd693b81b1e2d5a
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	FAT4 EPHA6 DOCK10 OVOS2 SMOC1 ZFHX4 CNTNAP2	2.38e-05	200	189	7	d0167f96314be78b6d867bbcc6e4396071d931b8
ToppCell	Kidney-Fibroblasts\|Kidney / Skin and Kidney Cells in Lupus Nephritis Patients.	WNT11 ITPRID1 TNNI3K FBLN1 KLHL25 ZFHX4 RAB40C	2.38e-05	200	189	7	2c265ad8314a21bce50ac21b16da2fea125366ea
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK10 RENBP ITGA9 RGS13 STAP1 VWA5A ATP2A3	2.38e-05	200	189	7	566fe2e78e6f35399ec6aad5964f6d4d8ade82c6
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|Control_saline / Treatment groups by lineage, cell group, cell type	FAT4 HTR4 ITGA9 KANK2 ADAMTS12 FBLN1 ZFHX4	2.38e-05	200	189	7	a799fc7bb83ad0524362cb5010df949741fb7bf3
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Interneuron\|5w / Sample Type, Dataset, Time_group, and Cell type.	APC RUNX1T1 LRRN3 EML5 CNTNAP2 RASD1 ZFHX3	2.38e-05	200	189	7	c7e33057466915d4e2b34f2062b22d9cdffa69dc
ToppCell	healthy_donor-Lymphocytic-T_cell-CD4+_T_cell_(ISG_high)\|healthy_donor / Disease condition, Lineage, Cell class and subclass	ZSWIM5 SPEG CD274 ZNF624 PLCG1 DNAH5	2.75e-05	138	189	6	97f5dc17522462133e582b508ad0ef036e656872
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CALHM5 HTR4 CR2 STAP1 TAF7L MYBPC1	3.50e-05	144	189	6	cc11cce43d1af8ac63140d05faf215ae9a10cde1
ToppCell	5'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related-Tuft\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CACNA2D2 ITPRID1 ADCY7 RGS13 ZFHX3 ATP2A3	6.74e-05	162	189	6	80619a93c57fe16daf91dc571874ef9ac888953d
ToppCell	Control-B_intermediate-10\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	PSAP TENT5A RGS13 SLCO4C1 TLN1 ACSM5	6.74e-05	162	189	6	aa80452b972bb8ad3670ffaba4ce26fadb33b185
ToppCell	ASK428-Immune-Mast_cell\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	ELOA2 TENT5A RENBP RGS13 STAP1 VWA5A	6.98e-05	163	189	6	569ca0e8ce307f258910b0c75c498009a9651e6e
ToppCell	NS-moderate-d_16-33-Myeloid-Mast_cell\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CACNA2D2 TENT5A RGS13 STAP1 TTLL7 VWA5A	7.22e-05	164	189	6	35c673380f75cb4bfe080089bc723c4373bcc7a5
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic-Mast_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LDHAL6B DOCK10 ITGA9 RGS13 VWA5A CD274	7.22e-05	164	189	6	2c48c6e4eeee845f0563982d0bfa2a176ca5ef61
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-neuronal_stem_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO19 TENT5A ITGA9 S100A3 JRK DNAH5	7.46e-05	165	189	6	1703d3eb644b3c743ad3c5532b1d29ea010c79c8
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GPR21 ANGPT2 CCND1 ROCK1 ZFHX3 ENPEP	7.46e-05	165	189	6	3d14f37b8a9c0ddc1130e60a2e08556bad1fb855
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Htr2c\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	TENT5A DOCK10 PFKFB3 SMOC1 CNTNAP2 MYBPC1	7.46e-05	165	189	6	c6b23013d77fa9aa967b76e451c8e42b0a657c30
ToppCell	facs-Heart-RA-18m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAG1 BACH2 CR2 STAP1 GPR171 ATP2A3	7.72e-05	166	189	6	fc2cf67311c86fda75b35fcd4768b6f6f14c59d0
ToppCell	facs-Heart-RA-18m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAG1 BACH2 CR2 STAP1 GPR171 ATP2A3	7.72e-05	166	189	6	33a6876d06e26176135a73a77c19e634ec53f7ce
ToppCell	control-Epithelial-Ionocyte\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	SMOC1 RUNX1T1 STAP1 HSPA12A RASD1 ATP2A3	8.24e-05	168	189	6	327b02f19f4a8607c033203824fdc60a1254331f
ToppCell	368C-Fibroblasts-Fibroblast-C_(Myofibroblast)\|368C / Donor, Lineage, Cell class and subclass (all cells)	B3GALNT1 RUNX1T1 RGS13 ADAMTS12 LRRN3 ENPEP	8.24e-05	168	189	6	1bc6a1915d48f547385ed4f44e118bcc8a4a7b6c
ToppCell	Control-B_cells-Activated_B_cells\|Control / group, cell type (main and fine annotations)	SMCHD1 BACH2 DOCK10 STAP1 CNTNAP2 ATP2A3	8.24e-05	168	189	6	a7159a35fe37f8c241cf8d391debe271e0698105
ToppCell	368C-Fibroblasts-Fibroblast-C_(Myofibroblast)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	B3GALNT1 RUNX1T1 RGS13 ADAMTS12 LRRN3 ENPEP	8.24e-05	168	189	6	69f534de0f9a293047bea03cb1b78551087a8df5
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_amplifying_undifferentiated_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPR21 CCND1 KANK2 ZFHX3 MTREX TBCEL	8.24e-05	168	189	6	d69452e2cfeb74023b5cf3d09064d7dcad0008ec
ToppCell	5'-Adult-Appendix-Hematopoietic-T_cells-TRGV2_gdT\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DOCK10 PFKFB3 ANTXRL CEP120 GPR171 MGA	8.52e-05	169	189	6	8caf7996796a2e2716e3855de855c903d6126bf2
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DCDC1 SAXO2 CFAP65 DLEC1 DNAH5 DRC3	8.52e-05	169	189	6	14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f
ToppCell	390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	B3GALNT1 S100A3 CEP120 CD274 GPR171 FOXF1	8.80e-05	170	189	6	a6fa0cab1fa829ec601fe48306b4c43c83425b04
ToppCell	390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	B3GALNT1 S100A3 CEP120 CD274 GPR171 FOXF1	8.80e-05	170	189	6	b40255eee45eb18b5a297336d7f3845fd8f8aa3b
Drug	Methylhydantoin-5-(L) [40856-73-3]; Down 200; 35uM; MCF7; HT_HG-U133A	ERCC6 APC SRCAP DNAJC6 VPS13D NF1 MAST4 ZFHX4 NFX1 ALCAM TBCEL	6.74e-07	193	189	11	3378_DN
Drug	(-)-Quinpirole hydrochloride [85760-74-3]; Down 200; 15.6uM; MCF7; HT_HG-U133A	ERCC6 LARP6 APC AP4E1 RIF1 HSPA12A VPS13D NF1 MARK4 DAGLA ENPEP	7.09e-07	194	189	11	3539_DN
Drug	Cefamandole sodium salt [30034-03-8]; Down 200; 8.2uM; MCF7; HT_HG-U133A	ELOA2 APC ELSPBP1 MAPK8IP3 VPS13D TLN1 MARK4 LRP6 ENPEP SNTA1 SPINK5	7.85e-07	196	189	11	4718_DN
Drug	Tremorine dihydrochloride [300-68-5]; Down 200; 15uM; PC3; HT_HG-U133A	TMC7 APC SRCAP FBLN1 NF1 ZBED4 SIPA1L1 RHOBTB2 MARK4 NFX1 TRAPPC14	8.68e-07	198	189	11	5799_DN
Drug	agelasine B	CCND1 RASD1 ATP2A1 ATP2A2 ATP2A3 EPHB1	2.15e-06	46	189	6	CID006439899
Drug	Reserpinic acid hydrochloride; Up 200; 9.2uM; MCF7; HT_HG-U133A	CACNA2D2 SRCAP AP4E1 FBLN1 NF1 ZNF592 SERPINA10 ATP2A2 DAGLA EPHB1	5.63e-06	195	189	10	7323_UP
Drug	3-Acetamidocoumarin [779-30-6]; Up 200; 19.6uM; MCF7; HT_HG-U133A	GNE DNAJC6 AP4E1 FBLN1 HSPA12A VPS13D SIPA1L1 MARK4 ATP2A2 DAGLA	5.63e-06	195	189	10	7361_UP
Drug	3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; MCF7; HT_HG-U133A	ELSPBP1 FBLN1 NF1 MAST4 CNTNAP2 ALCAM PLCG1 ATP2A3 ENPEP TBCEL	6.16e-06	197	189	10	4764_DN
Drug	Vincamine [1617-90-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A	ELSPBP1 MAPK8IP3 FBLN1 LRRN3 KLHL25 SCARB1 RHOBTB2 LRP6 DAGLA SPINK5	6.16e-06	197	189	10	2327_DN
Drug	Dihydrostreptomycin sulfate [5490-27-7]; Up 200; 2.8uM; PC3; HT_HG-U133A	HTR4 APC MAGEC3 SRCAP ELSPBP1 FBLN1 VPS13D NF1 TBCEL ZNF639	6.16e-06	197	189	10	5751_UP
Drug	Iobenguane sulfate; Up 200; 10.8uM; MCF7; HT_HG-U133A	ERCC6 LARP6 APC SRCAP KLHL25 NF1 ALCAM ATP2A2 TBCEL DRC3	6.44e-06	198	189	10	2878_UP
Drug	Isopyrin hydrochloride [18342-39-7]; Down 200; 14.2uM; MCF7; HT_HG-U133A	SRCAP MAPK8IP3 HSPA12A VPS13D KLHL25 VWA5A SIPA1L1 MARK4 RAB40C TRAPPC14	6.74e-06	199	189	10	6097_DN
Drug	Hemicholinium bromide [312-45-8]; Up 200; 7uM; MCF7; HT_HG-U133A	RUNX1T1 ELSPBP1 MAPK8IP3 AP4E1 VPS13D CNTNAP2 ACSM5 ATP2A3 ZNF639 SPINK5	6.74e-06	199	189	10	3216_UP
Drug	irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A	ZMYM2 MAST4 PSME4 ZFHX4 UBR5 SIPA1L1 ANKRD17 ROCK1 MGA	1.36e-05	171	189	9	7535_DN
Drug	Norcyclobenzaprine [303-50-4]; Up 200; 15.4uM; PC3; HT_HG-U133A	ELOA2 HTR4 APC MAPK8IP3 FBLN1 NF1 MAST4 SCARB1 CNTNAP2	3.26e-05	191	189	9	4190_UP
Drug	Naltrexone hydrochloride dihydrate [16676-29-2]; Up 200; 9.6uM; MCF7; HT_HG-U133A	SPEG DOCK10 APC TSHR MAPK8IP3 FBLN1 ABHD17B CD86 SIPA1L1	3.53e-05	193	189	9	2209_UP
Drug	Alprostadil [745-65-3]; Down 200; 11.2uM; MCF7; HT_HG-U133A	APC AP4E1 FBLN1 VPS13D KLHL25 NF1 ZBED4 VWA5A SPINK5	3.53e-05	193	189	9	4179_DN
Drug	Etanidazole [22668-01-5]; Down 200; 18.6uM; MCF7; HT_HG-U133A	ELSPBP1 VPS13D NF1 VWA5A SIPA1L1 MARK4 RAB40C PLCG1 TRAPPC14	3.68e-05	194	189	9	6072_DN
Drug	Quinethazone [73-49-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A	LARP6 TMC7 SEC22A MAPK8IP3 VPS13D NF1 MAST4 SIPA1L1 SNTA1	3.68e-05	194	189	9	3875_DN
Drug	Acyclovir [59277-89-3]; Down 200; 17.8uM; MCF7; HT_HG-U133A	LARP6 APC SRCAP VPS13D ABHD17B SCARB1 MARK4 PLCG1 ZNF639	3.68e-05	194	189	9	5278_DN
Drug	Lobelanidine hydrochloride [6112-86-3]; Up 200; 10.6uM; MCF7; HT_HG-U133A	LARP6 SRCAP VPS13D KLHL25 CNTNAP2 NFX1 RAB40C ATP2A3 DAGLA	3.83e-05	195	189	9	2897_UP
Drug	3-Acetylcoumarin [3949-36-8]; Down 200; 21.2uM; PC3; HT_HG-U133A	ELSPBP1 MAPK8IP3 AP4E1 KLHL25 PSME4 SCARB1 CNTNAP2 PLCG1 TRAPPC14	3.83e-05	195	189	9	4664_DN
Drug	Cephalothin sodium salt [58-71-9]; Up 200; 9.6uM; PC3; HT_HG-U133A	FAT4 ELOA2 APC ELSPBP1 AP4E1 MAST4 VWA5A PLCG1 DRC3	3.99e-05	196	189	9	4482_UP
Drug	Droperidol [548-73-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A	TRAF2 ZMYM2 VPS13D KLHL25 NF1 SIPA1L1 DAGLA SLC27A5 SPINK5	3.99e-05	196	189	9	2645_DN
Drug	haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A	SRCAP LRRN3 MAST4 VWA5A MARK4 TRAPPC14 ATP2A3 SNTA1 ZNF639	3.99e-05	196	189	9	5604_DN
Drug	Heliotrine [303-33-3]; Up 200; 12.8uM; MCF7; HT_HG-U133A	APC SRCAP FBLN1 NF1 VWA5A MARK4 CNTNAP2 ALCAM ZNF639	3.99e-05	196	189	9	4739_UP
Drug	Suxibuzone [27470-51-5]; Down 200; 9.2uM; MCF7; HT_HG-U133A	LARP6 HTR4 MAPK8IP3 KLHL25 NF1 SIPA1L1 SCARB1 MARK4 NFX1	3.99e-05	196	189	9	6065_DN
Drug	Nitrofurantoin [67-20-9]; Down 200; 16.8uM; MCF7; HT_HG-U133A	APC MAPK8IP3 FBLN1 VPS13D NF1 MARK4 NFX1 ENPEP SPINK5	3.99e-05	196	189	9	4697_DN
Drug	Propofol [2078-54-8]; Up 200; 22.4uM; HL60; HT_HG-U133A	HTR4 TMC7 APC CCND1 TSHR ITGA9 MAST4 ZFHX3 TBCEL	4.15e-05	197	189	9	3048_UP
Drug	Fluocinonide [356-12-7]; Down 200; 8uM; MCF7; HT_HG-U133A	HTR4 DOCK10 ADCY7 MAPK8IP3 HSPA12A PSME4 VWA5A MARK4 RAB40C	4.15e-05	197	189	9	3933_DN
Drug	Sulfanilamide [63-74-1]; Down 200; 23.2uM; PC3; HT_HG-U133A	SPEG BACH2 APC S100A3 NF1 ZBED4 RHOBTB2 MARK4 LRP6	4.15e-05	197	189	9	4474_DN
Drug	Rauwolscine hydrochloride [6211-32-1]; Up 200; 10.2uM; MCF7; HT_HG-U133A	APC MAPK8IP3 AP4E1 VPS13D NF1 ABHD17B MARK4 ENPEP ZNF639	4.15e-05	197	189	9	6274_UP
Drug	Methacycline hydrochloride [3963-95-9]; Down 200; 8.4uM; MCF7; HT_HG-U133A	TRAF2 MECOM ABHD17B TLN1 LRP6 ZFHX3 ALCAM TRAPPC14 MCOLN3	4.15e-05	197	189	9	7321_DN
Drug	(S)-(-)-Cycloserine [339-72-0]; Down 200; 39.2uM; MCF7; HT_HG-U133A	APC SRCAP MAPK8IP3 FBLN1 VPS13D ZNF592 MARK4 ATP2A3 SNTA1	4.15e-05	197	189	9	3870_DN
Drug	Isocarboxazid [59-63-2]; Down 200; 17.2uM; PC3; HT_HG-U133A	SPEG ZMYM2 ELSPBP1 DNAJC6 FBLN1 NF1 CNTNAP2 NFX1 TRAPPC14	4.15e-05	197	189	9	7383_DN
Drug	Oxamniquine [21738-42-1]; Up 200; 14.4uM; MCF7; HT_HG-U133A	CACNA2D2 DOCK10 MAPK8IP3 RIF1 VPS13D NF1 RHOBTB2 LRP6 SKA1	4.15e-05	197	189	9	7344_UP
Drug	Apramycin [37321-09-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A	CACNA2D2 RIF1 NF1 ZFHX4 SIPA1L1 RHOBTB2 ATP2A2 ZNF639 SPINK5	4.15e-05	197	189	9	7334_UP
Drug	5707885; Down 200; 50uM; MCF7; HT_HG-U133A	CACNA2D2 SPEG DOCK10 SRCAP MAPK8IP3 S100A3 RIF1 NF1 TRAPPC14	4.15e-05	197	189	9	6385_DN
Drug	Meclofenamic acid sodium salt monohydrate [6385-02-0]; Up 200; 11.8uM; PC3; HT_HG-U133A	B3GALNT1 TMC7 DOCK10 C2CD3 NF1 ZBED4 NFX1 LRP6 DAGLA	4.31e-05	198	189	9	7280_UP
Drug	Biperiden hydrochloride [1235-82-1]; Up 200; 11.4uM; PC3; HT_HG-U133A	TRAF2 DOCK10 APC HSPA12A NF1 ABHD17B NFX1 TBCEL DRC3	4.31e-05	198	189	9	4684_UP
Drug	Alfaxalone [23930-19-0]; Down 200; 12uM; MCF7; HT_HG-U133A	ERCC6 ADCY7 FBLN1 NF1 MAST4 SIPA1L1 CNTNAP2 NFX1 PLCG1	4.31e-05	198	189	9	5451_DN
Drug	Sulconazole nitrate [61318-91-0]; Up 200; 8.6uM; HL60; HT_HG-U133A	HTR4 ACSM1 TSHR CNTNAP2 ZFHX3 PLCG1 MCOLN3 DRC3 EPHB1	4.31e-05	198	189	9	3035_UP
Drug	Propantheline bromide [50-34-0]; Up 200; 9uM; PC3; HT_HG-U133A	ELOA2 HTR4 TSHR SRCAP MAPK8IP3 S100A3 NF1 VWA5A SCARB1	4.31e-05	198	189	9	4214_UP
Drug	Aceclofenac [89796-99-6]; Down 200; 11.2uM; MCF7; HT_HG-U133A	APC SRCAP VPS13D NF1 ZBED4 RHOBTB2 LRP6 SNTA1 MCOLN3	4.31e-05	198	189	9	2281_DN
Drug	(1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Up 200; 11.8uM; PC3; HT_HG-U133A	RAG1 ELOA2 APC RUNX1T1 SRCAP MAPK8IP3 LRRN3 NF1 RAB40C	4.31e-05	198	189	9	3810_UP
Drug	Dipyridamole [58-32-2]; Up 200; 8uM; MCF7; HT_HG-U133A	KLK15 LARP6 HTR4 SRCAP RIF1 FBLN1 KLHL25 CD86 ZNF639	4.31e-05	198	189	9	5617_UP
Drug	Furosemide [54-31-9]; Up 200; 12uM; MCF7; HT_HG-U133A	SPEG MAPK8IP3 TTLL7 LRRN3 VPS13D VWA5A ATP2A1 ATP2A2 ZNF639	4.49e-05	199	189	9	6841_UP
Drug	Mephenytoin [50-12-4]; Up 200; 18.4uM; MCF7; HT_HG-U133A	ELOA2 CCR9 TTLL7 FBLN1 NF1 CNTNAP2 LRP6 ATP2A3 ZNF639	4.49e-05	199	189	9	3580_UP
Drug	Condelphine [7633-69-4]; Up 200; 8.8uM; PC3; HT_HG-U133A	CACNA2D2 ZMYM2 SRCAP LRRN3 KLHL25 NF1 VWA5A ENPEP ZNF639	4.49e-05	199	189	9	6357_UP
Drug	Remoxipride Hydrochloride [73220-03-8]; Down 200; 9.8uM; MCF7; HT_HG-U133A	ADCY7 MAPK8IP3 MAST4 ABHD17B SIPA1L1 RHOBTB2 MARK4 CNTNAP2 PLCG1	4.49e-05	199	189	9	5443_DN
Drug	Carbenoxolone disodium salt [7421-40-1]; Up 200; 6.6uM; MCF7; HT_HG-U133A	DOCK10 APC RUNX1T1 ELSPBP1 MAPK8IP3 FBLN1 NF1 ATP2A2 TBCEL	4.49e-05	199	189	9	3353_UP
Drug	Papaverine hydrochloride [61-25-6]; Down 200; 10.6uM; PC3; HT_HG-U133A	TRAF2 SPEG APC SRCAP TTLL7 FBLN1 VPS13D NF1 PLCG1	4.49e-05	199	189	9	5769_DN
Drug	Loperamide hydrochloride [34552-83-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A	TMC7 NF1 P2RY2 SIPA1L1 RHOBTB2 MARK4 LRP6 ATP2A2 ATP2A3	4.66e-05	200	189	9	5632_DN
Drug	Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A	CACNA2D2 MAPK8IP3 AP4E1 FBLN1 MARK4 TRAPPC14 ATP2A3 ENPEP SPINK5	4.66e-05	200	189	9	2323_DN
Drug	Chloroprene	MYO1G EPRS1 AMPD2 FAT4 CALHM5 TMC7 CCR9 SMCHD1 ACSM1 TOPBP1 PFKFB3 RUNX1T1 TEX11 ADCY7 STAP1 TTLL7 RIF1 LRRN3 SLCO4C1 ZFHX4 ERCC6L2 RASD1 LRP6 ROCK1 GPR171 MGA	5.31e-05	1348	189	26	ctd:D002737
Drug	ATP-EDC	ATP2A1 ATP2A2 ATP2A3	6.47e-05	10	189	3	CID000195647
Drug	1sqc	ATP2A1 ATP2A2 ATP2A3	6.47e-05	10	189	3	CID000444279
Drug	MDCC fluorophore	NF1 RASD1	6.85e-05	2	189	2	CID000158349
Drug	APCP	APC NF1	6.85e-05	2	189	2	CID003083759
Drug	2,5-dimethylquinone	ATP2A1 ATP2A2 ATP2A3	8.85e-05	11	189	3	CID000008718
Drug	phosphocreatine disodium	AMPD2 LDHAL6B RIF1 ATP2A1 ATP2A2 ATP2A3 MYBPC1	8.93e-05	126	189	7	CID000000587
Drug	AC1L1KS5	CACNA2D2 ADCY7 P2RY2 RASD1 ROCK1 PLCG1 ATP2A1 ATP2A2 ATP2A3 DAGLA CACNA2D3	1.16e-04	334	189	11	CID000005631
Drug	1vyq	ATP2A1 ATP2A2 ATP2A3	1.17e-04	12	189	3	CID004369390
Drug	Loperamide hydrochloride [34552-83-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A	LARP6 RUNX1T1 CHRM5 FBLN1 VWA5A CD86 RAB40C SERPINA10	1.63e-04	185	189	8	5632_UP
Drug	Fluticasone propionate [80474-14-2]; Down 200; 8uM; HL60; HT_HG-U133A	DOCK10 CCND1 STAP1 MAPK8IP3 AP4E1 LRP6 ATP2A3 SLC27A5	1.88e-04	189	189	8	2928_DN
Drug	p-hydroxyhippuric acid	ATP2A1 ATP2A2 ATP2A3	1.92e-04	14	189	3	CID000151012
Drug	Ald1.1-H_000455; Up 200; 10uM; MCF7; HT_HG-U133A	ELOA2 MAPK8IP3 NF1 ABHD17B ZFHX4 ENPEP ZNF639 DRC3	2.02e-04	191	189	8	7542_UP
Drug	1-piperidineethanol	HTR4 RUNX1T1	2.05e-04	3	189	2	CID000018232
Drug	Methimazole [60-56-0]; Up 200; 35uM; MCF7; HT_HG-U133A	LARP6 CACNA2D2 APC ZMYM2 KLHL25 CNTNAP2 ATP2A3 ENPEP	2.10e-04	192	189	8	3432_UP
Drug	Lasalocid sodium salt [25999-20-6]; Down 200; 6.6uM; PC3; HT_HG-U133A	CACNA2D2 APC MAPK8IP3 NF1 SCARB1 MARK4 CNTNAP2 LRP6	2.10e-04	192	189	8	6639_DN
Drug	Dipyrone [5907-38-0]; Down 200; 12uM; MCF7; HT_HG-U133A	HTR4 SRCAP AP4E1 KLHL25 NF1 ABHD17B MARK4 ALCAM	2.10e-04	192	189	8	3929_DN
Drug	Dihydroergotoxine mesylate [8067-24-1]; Down 200; 6.4uM; MCF7; HT_HG-U133A	FBLN1 KLHL25 NF1 P2RY2 RHOBTB2 SNTA1 TBCEL SPINK5	2.10e-04	192	189	8	4152_DN
Drug	Cyanocobalamin [68-19-9]; Down 200; 3uM; MCF7; HT_HG-U133A	ERCC6 LARP6 SRCAP MAPK8IP3 NF1 ABHD17B ALCAM SPINK5	2.10e-04	192	189	8	4395_DN
Drug	Ergocryptine-alpha [511-09-1]; Up 200; 7uM; HL60; HT_HG-U133A	DOCK10 VPS13D CD86 SIPA1L1 ZFHX3 DAGLA ENPEP EPHB1	2.10e-04	192	189	8	2572_UP
Drug	Ketotifen fumarate [34580-14-8]; Down 200; 9.4uM; MCF7; HT_HG-U133A	ELOA2 SRCAP ADCY7 VPS13D NF1 SCARB1 MARK4 LRP6	2.17e-04	193	189	8	3200_DN
Drug	Isotretinoin [4759-48-2]; Up 200; 13.4uM; PC3; HT_HG-U133A	APC RUNX1T1 SRCAP DNAJC6 MAPK8IP3 TTLL7 TRAPPC14 DAGLA	2.17e-04	193	189	8	7315_UP
Drug	trifluoperazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A	LRRN3 NF1 VWA5A RHOBTB2 MARK4 CNTNAP2 LRP6 ATP2A3	2.17e-04	193	189	8	5584_DN
Drug	Penbutolol sulfate [38363-32-5]; Up 200; 5.8uM; MCF7; HT_HG-U133A	SPEG MAPK8IP3 AP4E1 TGIF1 FBLN1 NF1 TLN1 ATP2A3	2.17e-04	193	189	8	3534_UP
Drug	(S)-(-)-Cycloserine [339-72-0]; Up 200; 39.2uM; MCF7; HT_HG-U133A	DOCK10 APC RIF1 NF1 ZBED4 TAF7L ALCAM TBCEL	2.17e-04	193	189	8	3870_UP
Drug	2-propylpentanoic acid; Up 200; 50uM; HL60; HT_HG-U133A	FAT4 ANGPT2 HSPA12A VPS13D RHOBTB2 CNTNAP2 PLCG1 SNTA1	2.17e-04	193	189	8	2682_UP
Drug	Furaltadone hydrochloride [3759-92-0]; Down 200; 11uM; MCF7; HT_HG-U133A	APC VPS13D KLHL25 NF1 ABHD17B MARK4 PLCG1 SPINK5	2.25e-04	194	189	8	3932_DN
Drug	Sulfameter [651-06-9]; Down 200; 14.2uM; PC3; HT_HG-U133A	MAPK8IP3 ABHD17B MARK4 LRP6 ZFHX3 PLCG1 TRAPPC14 SKA1	2.25e-04	194	189	8	5732_DN
Drug	Fusaric acid [536-69-6]; Up 200; 22.4uM; HL60; HT_HG-U133A	TMC7 DNAJC6 STAP1 VPS13D ZFHX4 RHOBTB2 PLCG1 TRAPPC14	2.25e-04	194	189	8	1308_UP
Drug	Naproxen [22204-53-1]; Down 200; 17.4uM; MCF7; HT_HG-U133A	SRCAP MAPK8IP3 FBLN1 KLHL25 NF1 CNTNAP2 PLCG1 TRAPPC14	2.25e-04	194	189	8	5457_DN
Drug	Meptazinol hydrochloride [59263-76-2]; Up 200; 14.8uM; MCF7; HT_HG-U133A	HTR4 GNE AP4E1 HSPA12A VPS13D NF1 ATP2A2 SNTA1	2.33e-04	195	189	8	7326_UP
Drug	Thiocolchicoside [602-41-5]; Down 200; 7uM; MCF7; HT_HG-U133A	ELSPBP1 SEC22A MAPK8IP3 NF1 MAST4 VWA5A PLCG1 TRAPPC14	2.33e-04	195	189	8	5520_DN
Drug	Bisoprolol fumarate; Up 200; 9uM; MCF7; HT_HG-U133A	TRAF2 ELOA2 APC VWA5A ALCAM PLCG1 DAGLA SPINK5	2.33e-04	195	189	8	5348_UP
Drug	Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Down 200; 5.8uM; PC3; HT_HG-U133A	EPRS1 APC ZMYM2 MAPK8IP3 NF1 ZBED4 TRAPPC14 ZNF639	2.33e-04	195	189	8	4508_DN
Drug	Dipyridamole [58-32-2]; Up 200; 8uM; MCF7; HT_HG-U133A	HTR4 CACNA2D2 ADCY7 MAST4 VWA5A MARK4 SNTA1 ZNF639	2.33e-04	195	189	8	1517_UP
Drug	Tiabendazole [148-79-8]; Down 200; 19.8uM; MCF7; HT_HG-U133A	SRCAP FBLN1 VPS13D KLHL25 SIPA1L1 SCARB1 ATP2A3 ENPEP	2.33e-04	195	189	8	4402_DN
Drug	Flavoxate hydrochloride [3717-88-2]; Down 200; 9.4uM; MCF7; HT_HG-U133A	APC ADCY7 FBLN1 VPS13D NF1 MARK4 NFX1 ALCAM	2.33e-04	195	189	8	5427_DN
Drug	Risperidone [106266-06-2]; Down 200; 9.8uM; MCF7; HT_HG-U133A	MAPK8IP3 AP4E1 RIF1 NF1 MAST4 MARK4 DAGLA ZNF639	2.33e-04	195	189	8	3508_DN
Drug	diclofenac sodium; Up 200; 10uM; PC3; HG-U133A	TRAF2 HTR4 APC KLHL25 VWA5A CD86 ACSM5 TRAPPC14	2.33e-04	195	189	8	445_UP
Drug	Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A	CACNA2D2 SRCAP ELSPBP1 FBLN1 NF1 MARK4 RAB40C TRAPPC14	2.33e-04	195	189	8	4180_DN
Drug	Tiaprofenic acid [33005-95-7]; Down 200; 15.4uM; MCF7; HT_HG-U133A	SRCAP MAPK8IP3 AP4E1 NF1 MAST4 MARK4 ENPEP ZNF639	2.33e-04	195	189	8	2852_DN
Drug	Piromidic acid [19562-30-2]; Down 200; 13.8uM; MCF7; HT_HG-U133A	APC ZMYM2 MAPK8IP3 HSPA12A NF1 PSME4 TRAPPC14 SNTA1	2.33e-04	195	189	8	4398_DN
Drug	NSC239129	ATP2A1 ATP2A2 ATP2A3	2.38e-04	15	189	3	CID000084597
Drug	Molindone hydrochloride [15622-65-8]; Up 200; 12.8uM; MCF7; HT_HG-U133A	APC LRRN3 VPS13D NF1 ZFHX4 MARK4 SNTA1 MCOLN3	2.41e-04	196	189	8	4784_UP
Drug	Timolol maleate salt [26921-17-5]; Down 200; 9.2uM; MCF7; HT_HG-U133A	ERCC6 LARP6 APC SRCAP KLHL25 MARK4 CNTNAP2 TBCEL	2.41e-04	196	189	8	5280_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	ERCC6 APC SRCAP MAPK8IP3 FBLN1 NF1 SIPA1L1 MARK4	2.41e-04	196	189	8	3872_DN
Disease	Brody myopathy (implicated_via_orthology)	ATP2A1 ATP2A2 ATP2A3	2.27e-07	3	181	3	DOID:0050692 (implicated_via_orthology)
Disease	Stuttering, Familial Persistent 1	AP4E1 CNTNAP2	3.74e-05	2	181	2	C3489627
Disease	Adenoma, Microcystic	APC TSHR NF1 ATP2A3	6.92e-05	36	181	4	C0205648
Disease	Adenoma, Monomorphic	APC TSHR NF1 ATP2A3	6.92e-05	36	181	4	C0205649
Disease	Adenoma, Basal Cell	APC TSHR NF1 ATP2A3	6.92e-05	36	181	4	C0205646
Disease	Follicular adenoma	APC TSHR NF1 ATP2A3	6.92e-05	36	181	4	C0205647
Disease	Papillary adenoma	APC TSHR NF1 ATP2A3	6.92e-05	36	181	4	C0205650
Disease	Adenoma, Trabecular	APC TSHR NF1 ATP2A3	6.92e-05	36	181	4	C0205651
Disease	Adenoma	APC TSHR NF1 ATP2A3	6.92e-05	36	181	4	C0001430
Disease	FEV/FEC ratio	ABHD17A HTR4 SPEG BACH2 KIF1B MECOM CCND1 RUNX1T1 FBLN1 KLHL25 CNTNAP2 ERCC6L2 ZFHX3 DLEC1 DENND5A MGA DNAH5 PCDH10 ATP2A3 CACNA2D3	7.09e-05	1228	181	20	EFO_0004713
Disease	chronic obstructive pulmonary disease	HTR4 SPEG BACH2 KIF1B DOCK10 MECOM ERCC6L2 DLEC1 DOT1L DNAH5 ATP2A2 ATP2A3 GABBR1 CACNA2D3	9.57e-05	688	181	14	EFO_0000341
Disease	Benign neoplasm of stomach	ATR APC UBR5	1.45e-04	17	181	3	C0153943
Disease	Neoplasm of uncertain or unknown behavior of stomach	ATR APC UBR5	1.45e-04	17	181	3	C0496905
Disease	Carcinoma in situ of stomach	ATR APC UBR5	1.45e-04	17	181	3	C0154060
Disease	glucose homeostasis measurement, acute insulin response measurement	P2RY2 ATP2A2 ATP2A3	1.73e-04	18	181	3	EFO_0006831, EFO_0006896
Disease	Hemangiosarcoma	ANGPT2 CCND1 PLCG1	1.73e-04	18	181	3	C0018923
Disease	latent autoimmune diabetes in adults	BACH2 PFKFB3	2.23e-04	4	181	2	EFO_0009706
Disease	bipolar I disorder	MYO1G TDRD15 CACNA2D2 MYO19 ZNF592 ATP2A2	2.42e-04	141	181	6	EFO_0009963
Disease	Stomach Carcinoma	ATR APC UBR5	2.78e-04	21	181	3	C0699791
Disease	otitis media (implicated_via_orthology)	MECOM TGIF1 DNAH5	3.21e-04	22	181	3	DOID:10754 (implicated_via_orthology)
Disease	Intestinal Polyps	APC CCND1	3.70e-04	5	181	2	C0021846
Disease	Schizophrenia	HTR4 ACSM1 APC CCND1 CHRM5 ADCY7 CFAP65 ADAMTS12 HSPA12A EML5 PI4KA CNTNAP2 TRPM1 ATP2A2 GABBR1	3.80e-04	883	181	15	C0036341
Disease	level of Sterol ester (27:1/18:2) in blood serum	TDRD15 MARK4 ANKRD17	5.32e-04	26	181	3	OBA_2045194
Disease	monocyte percentage of leukocytes	MYO1G HTR4 TENT5A BACH2 KIF1B DOCK10 MECOM TGIF1 NF1 P2RY2 PI4KA SCARB1 MARK4	6.13e-04	731	181	13	EFO_0007989
Disease	multiple myeloma	MECOM CCND1 SRCAP CEP120 POLQ	6.49e-04	112	181	5	EFO_0001378
Disease	Akinetic Petit Mal	CACNA2D2 JRK	7.70e-04	7	181	2	C0001890
Disease	protein S measurement	DNAJC6 EPHB1	7.70e-04	7	181	2	EFO_0004637
Disease	Epilepsy, Absence, Atypical	CACNA2D2 JRK	7.70e-04	7	181	2	C0751124
Disease	Absence Seizure Disorder	CACNA2D2 JRK	7.70e-04	7	181	2	C4553705
Disease	Juvenile Absence Epilepsy	CACNA2D2 JRK	7.70e-04	7	181	2	C4317339
Disease	Childhood Absence Epilepsy	CACNA2D2 JRK	7.70e-04	7	181	2	C4281785
Disease	Epilepsy, Minor	CACNA2D2 JRK	7.70e-04	7	181	2	C4552765
Disease	Absence Epilepsy	CACNA2D2 JRK	7.70e-04	7	181	2	C0014553
Disease	common carotid intimal medial thickness	TDRD15 CNTNAP2 ERCC6L2 DLEC1	7.77e-04	67	181	4	EFO_0004860
Disease	visceral:subcutaneous adipose tissue ratio	BACH2 CEP120 CNTNAP2 EPHB1	9.16e-04	70	181	4	EFO_0004767
Disease	Urologic Neoplasms	ATR CCND1	1.02e-03	8	181	2	C0042076
Disease	Cancer of Urinary Tract	ATR CCND1	1.02e-03	8	181	2	C0751571
Disease	Acute Myeloid Leukemia, M1	BACH2 MECOM RUNX1T1 ADCY7 NF1	1.06e-03	125	181	5	C0026998
Disease	Acute Myeloid Leukemia (AML-M2)	BACH2 MECOM RUNX1T1 ADCY7 NF1	1.06e-03	125	181	5	C1879321
Disease	coronary artery disease	TDRD15 FAT4 PSAP TENT5A MECOM KANK2 MAPK8IP3 AP4E1 CEP120 MAST4 SCARB1 MARK4 DLEC1 ALCAM PLCG1 DENND5A GABBR1	1.14e-03	1194	181	17	EFO_0001645
Disease	aspartate aminotransferase measurement	CACNA2D2 KEAP1 ITGA9 TTLL7 ADAMTS12 METAP1 HSPA12A KLHL25 NF1 P2RY2 SCARB1 RHOBTB2 CNTNAP2 GABBR1	1.44e-03	904	181	14	EFO_0004736
Disease	BMI-adjusted waist-hip ratio, asthma	RBBP8 MECOM	1.63e-03	10	181	2	EFO_0007788, MONDO_0004979
Disease	heart disease (implicated_via_orthology)	ATP2A1 ATP2A2 ATP2A3	1.64e-03	38	181	3	DOID:114 (implicated_via_orthology)
Disease	lung non-small cell carcinoma (is_implicated_in)	ERCC6 TENT5A CCND1 ZFHX3 PLCG1	1.70e-03	139	181	5	DOID:3908 (is_implicated_in)
Disease	visual epilepsy (is_implicated_in)	CNTNAP2 ASPM	1.98e-03	11	181	2	DOID:11832 (is_implicated_in)
Disease	colon cancer (implicated_via_orthology)	ATR APC	1.98e-03	11	181	2	DOID:219 (implicated_via_orthology)
Disease	Myeloproliferative disease	ZMYM2 MECOM	2.37e-03	12	181	2	C0027022
Disease	platelet component distribution width	MYO1G TRAF2 DOCK10 MECOM TEX11 METTL13 P2RY2 TLN1 MARK4 DLEC1 RNF145 MYBPC1	2.53e-03	755	181	12	EFO_0007984
Disease	Benign tumor of pancreas	RBBP8 APC	2.79e-03	13	181	2	C0347284
Disease	gallbladder cancer (is_implicated_in)	APC KEAP1	2.79e-03	13	181	2	DOID:3121 (is_implicated_in)
Disease	selective IgA deficiency disease	PFKFB3 MAST4 CD86	2.84e-03	46	181	3	EFO_1001929
Disease	Adenocarcinoma of large intestine	APC TNNI3K UBR5 MARK4	2.93e-03	96	181	4	C1319315
Disease	schizophrenia, anorexia nervosa	GATAD2A ZNF592 ATP2A2	3.21e-03	48	181	3	MONDO_0005090, MONDO_0005351
Disease	phosphoglycerides measurement	TDRD15 KANK2 SCARB1	3.21e-03	48	181	3	EFO_0022291
Disease	Saldino-Noonan Syndrome	C2CD3 CEP120	3.24e-03	14	181	2	C0036069
Disease	esterified cholesterol measurement, low density lipoprotein cholesterol measurement	TDRD15 ANKRD17	3.24e-03	14	181	2	EFO_0004611, EFO_0008589
Disease	Adenoid Cystic Carcinoma	CCND1 SRCAP ASPM MGA	3.40e-03	100	181	4	C0010606
Disease	lung adenocarcinoma (is_implicated_in)	CCND1 UBR5 ZFHX3	3.40e-03	49	181	3	DOID:3910 (is_implicated_in)
Disease	acute myeloid leukemia (is_marker_for)	CCND1 NF1 CD86	3.40e-03	49	181	3	DOID:9119 (is_marker_for)
Disease	HSV2 virologic severity measurement	KIF1B CEP120	3.73e-03	15	181	2	EFO_0009010
Disease	sitting height ratio	MECOM TTK EPHB1	3.81e-03	51	181	3	EFO_0007118
Disease	mean arterial pressure	DCDC1 DOCK10 MECOM PFKFB3 SMOC1 MARK4 ZFHX3 ATP2A2 ENPEP	3.83e-03	499	181	9	EFO_0006340
Disease	lung non-small cell carcinoma (is_marker_for)	CCND1 ITGA9 NF1 UBR5 ZFHX3	3.96e-03	169	181	5	DOID:3908 (is_marker_for)
Disease	Major Depressive Disorder	ACSM1 CCND1 PFKFB3 ADCY7 CNTNAP2 ENPEP	3.98e-03	243	181	6	C1269683
Disease	Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse	CCND1 UBR5	4.24e-03	16	181	2	C0334634
Disease	primary autosomal recessive microcephaly (is_implicated_in)	ASPM TRAPPC14	4.24e-03	16	181	2	DOID:0070296 (is_implicated_in)
Disease	Pheochromocytoma, Extra-Adrenal	KIF1B NF1	4.24e-03	16	181	2	C1257877
Disease	Leukemia, Myelocytic, Acute	BACH2 MECOM RUNX1T1 ADCY7 NF1	4.37e-03	173	181	5	C0023467
Disease	Hypogammaglobulinemia	BACH2 CR2	4.79e-03	17	181	2	C0086438
Disease	body weight	C2orf69 EPHA6 SMCHD1 MECOM SMOC1 RUNX1T1 TEX11 TNNI3K CEP120 MAST4 JRK RASD1 ZFHX3 DOT1L MGA EPHB1	4.91e-03	1261	181	16	EFO_0004338
Disease	Prostatic Neoplasms	RAG1 ATR APC CCND1 KEAP1 FBLN1 RASD1 ZFHX3 MGA SPINK5	4.91e-03	616	181	10	C0033578
Disease	Malignant neoplasm of prostate	RAG1 ATR APC CCND1 KEAP1 FBLN1 RASD1 ZFHX3 MGA SPINK5	4.91e-03	616	181	10	C0376358
Disease	pancreatic cancer (is_implicated_in)	ATR APC CCND1 ITGA9	5.09e-03	112	181	4	DOID:1793 (is_implicated_in)
Disease	facial pigmentation measurement	ELSPBP1 CEP120 SCARB1	5.21e-03	57	181	3	EFO_0006942
Disease	hepatocellular carcinoma (is_implicated_in)	KIF1B APC CCND1 ZFHX3 PLCG1	5.28e-03	181	181	5	DOID:684 (is_implicated_in)
Disease	chromosomal aberration frequency	OR10J5 UBR5	5.37e-03	18	181	2	EFO_0009860
Disease	immature platelet fraction	KIF1B DOCK10 MARK4 RNF145	5.41e-03	114	181	4	EFO_0009187
Disease	Unipolar Depression	ACSM1 CCND1 PFKFB3 ADCY7 CNTNAP2 ENPEP	5.41e-03	259	181	6	C0041696
Disease	heart failure	HSPA12A ZNF592 SCARB1 ZFHX3 CCDC136	5.79e-03	185	181	5	EFO_0003144
Disease	X-12063 measurement	NF1 SKA1 DNAH5 PCDH10 CACNA2D3	5.92e-03	186	181	5	EFO_0021283
Disease	Congenital hernia of foramen of Morgagni	WNT11 FOXF1	5.97e-03	19	181	2	C0265699
Disease	Congenital hernia of foramen of Bochdalek	WNT11 FOXF1	5.97e-03	19	181	2	C0265700
Disease	Pancreatic carcinoma	RBBP8 APC	5.97e-03	19	181	2	C0235974
Disease	hippocampal tail volume	ITPRID1 MAST4	5.97e-03	19	181	2	EFO_0009398
Disease	Pheochromocytoma	KIF1B NF1	5.97e-03	19	181	2	C0031511
Disease	Lung Neoplasms	ERCC6 ACSM1 APC CCND1 TSHR CD274	6.04e-03	265	181	6	C0024121

Protein segments in the cluster

Peptide	Gene	Start	Entry
SNQLVSDRYVMPECF	TDRD5	511	Q8NAT2
MTDKCTTDEQPRKDY	BACH2	826	Q9BYV9
SRYDRTIQCMIESFP	CEACAM18	196	A8MTB9
QSPNIRMCFITYSTD	ANTXRL	106	A6NF34
KETPEYRCMQSQFSV	RNF20	376	Q5VTR2
FPSTQTCMERGYIKE	RBBP8	856	Q99708
RTCEKSDESAMSFYP	C2orf69	236	Q8N8R5
PETRESSCVMKQTQY	CACNA2D2	1006	Q9NY47
ESFTCSEMEYDREKP	FAT4	4846	Q6V0I7
TFPNSTEEIKAYCDM	ANGPT2	301	O15123
SGMRVAFPDTKKTYC	ABHD17A	216	Q96GS6
CMRTKSRDPLAIYFT	ACSM5	216	Q6NUN0
MLKAEETCAPSVSYF	CCND1	31	P24385
IDYDTKSFESMQRLC	DOT1L	61	Q8TEK3
MQDASRDLFTYTVKC	ADCY7	201	P51828
REKYMALSLQSFCPT	AMPD2	251	Q01433
QFPSDSECMRYIATI	ANKRD17	1411	O75179
PRNSYKCGTNTMERE	CD86	276	P42081
PTKEEMSLRAYTARC	ASPM	746	Q8IZT6
EFSRDRKSMSVYCSP	ATP2A1	486	O14983
EFSRDRKSMSVYCTP	ATP2A3	486	Q93084
MQCSEFDTVPYKNEL	ADAMTS12	606	P58397
CLPVMEAESTKSFQY	AP4E1	976	Q9UPM8
RIFSKYCDMTESNPL	CRISP1	76	P54107
VANESVPFETSCRYM	P4HTM	346	Q9NXG6
SIMHRKFSSAPCEVY	RAG1	181	P15918
VPTEQARAYAEKNCM	RAB40C	136	Q96S21
SYFMPDKLCTTLEDA	RBM46	441	Q8TBY0
EYGSNMTIECKFPVE	CD274	31	Q9NZQ7
MSPDLHRKVSVQYCD	RASD1	201	Q9Y272
AVALKQACTPMFREY	SHMT2	336	P34897
DFCYSSIIAPKMLVN	OR5D18	71	Q8NGL1
EMSCKTSPVRYKEEE	MECOM	1116	Q03112
LNERCMKFVPNETYF	ERCC6	721	P0DP91
SREPYMCAQCKTDFT	GATAD2A	411	Q86YP4
YTEMRFTVRDCSSLP	EPHB1	86	P54762
KVQRTIFSECFYTMA	RENBP	126	P51606
MICFKSVAKTPYDTS	ELOA2	641	Q8IYF1
AVSMTKTRNEVCGYP	DCDC1	1231	M0R2J8
CPMEQCKRNSTSIYF	CD58	161	P19256
TTYECLMQAIDAVKP	METAP1	251	P53582
SDQRMDSLVLCPTYF	MAGEC3	71	Q8TD91
LPYSRTTVEDFCMKI	DRG1	311	Q9Y295
SYLCTESDKIPMAQR	MAPK8IP3	506	Q9UPT6
YSSRVKISMPSCQDQ	MGA	1391	Q8IWI9
PYHDKFRSLNMVSEC	MCOLN3	436	Q8TDD5
ELYIPDMACAKTTTR	ITPRID1	516	Q6ZRS4
EYCQDRTEKHSTMPD	RUNX1T1	26	Q06455
CQPMDDAKYSVRTAA	MYO19	321	Q96H55
KKSMYSRVPECQVTT	EIF3L	301	Q9Y262
SSLDSEMCKDYRVLP	SPINK5	986	Q9NQ38
FKIYDPSINCTVDEM	GABBR1	401	Q9UBS5
QPAVITKDVCMVFYS	KIF1B	1396	O60333
KTLDTRTVDYCSIMP	CFAP65	431	Q6ZU64
VTEFCPNAKYVMKTD	B3GALNT1	166	O75752
DKSYPGRLTNTMVCA	KLK15	181	Q9H2R5
AKDFYEQMQLTEPCV	JRK	116	O75564
TKMPNIVCSKDYFVT	LDHAL6B	121	Q9BYZ2
DICYVSSTAPKMLSD	OR5A2	71	Q8NGI9
MEVKISSPDYKDCNS	PFKFB3	166	Q16875
MTNSSFFCPVYKDLE	GPR171	1	O14626
KEMVICSEASSTYQR	NFX1	896	Q12986
SERPACVKKDYSNFM	PI4KA	1126	P42356
PVRQSSDKMLYCEAE	LRRC74A	36	Q0VAA2
VCDSDYAPSRRMTSV	LRP6	1536	O75581
CSTSPEIFRKCMDYS	LARP6	406	Q9BRS8
FEKSVPMSTYLVCFA	ENPEP	276	Q07075
AYSFTKEPECIHVMR	HSPA12A	71	O43301
FTNLHYRKPEVCVME	OVOS2	661	Q6IE36
YQVCLTPESAKTDLM	PCDH10	821	Q9P2E7
DVCYISSTVPKMLSN	OR5AN1	71	Q8NGI8
MAYKVTRPLASANSC	P2RY2	286	P41231
SLPYATESKECRMVQ	FBLN1	51	P23142
CSVGFPFMRSKSKYE	ITGA9	706	Q13797
EFSRDRKSMSVYCTP	ATP2A2	486	P16615
AVSKSSYPMRVNRCK	ATR	2181	Q13535
RDMVSKVQCYDPSEN	KLHL25	456	Q9H0H3
IRCGPKQFTSYLTDM	C2CD3	96	Q4AC94
MVRFDPGTSIKYSCN	CR2	426	P20023
SDMPEYSVTNEFCRK	DOCK10	1136	Q96BY6
TCNRADYSKLAPIMF	GNE	16	Q9Y223
KFPLTEEEIFYMNCR	EFCAB7	26	A8K855
TMAPIEIRYNESLKC	CACNA2D3	1026	Q8IZS8
EVRKNMEVFLPQSYC	CEP120	496	Q8N960
VVAFKCPCSTENMTY	CALHM5	36	Q8N5C1
DVFRKVEMPSQYCLA	POLQ	2071	O75417
AICTMVYPSDESTKL	CCR9	196	P51686
STCTDFERMKEYRVQ	DNAJC6	266	O75061
FMVNKPYAITCSVVA	HTR4	186	Q13639
TFYEEVTSKQICSAM	DENND5A	136	Q6IQ26
LRTSMYQKCTTVDEA	DENND5A	621	Q6IQ26
PFYMSTDCESILRRF	MARK4	276	Q96L34
ENPFVVSMYCSFETR	MAST4	626	O15021
KSSSFQDLYCMVVPE	DAGLA	926	Q9Y4D2
FPSIYRNNVVSDCME	ELSPBP1	131	Q96BH3
YSRMNIKCSFAPMSD	KANK2	826	Q63ZY3
VMYASTECKAEVTPS	KEAP1	31	Q14145
VSYFCKMSRLLNTPD	CNTNAP2	686	Q9UHC6
SYCKDIPSFVIQMDF	EML5	1816	Q05BV3
TQECPELRFAYMVTT	CYP20A1	406	Q6UW02
NPISEAEDYKMFICA	DRC3	166	Q9H069
DRMVYCSLTDFQKAV	ERCC6L2	396	Q5T890
RPCYDVIMFDVDSKD	METTL13	566	Q8N6R0
EVQACPDKRYAMVLF	GPR21	241	Q99679
ECVARYQPKQRSMFT	FBXO30	506	Q8TB52
MDSIKCYPDKETAFS	DLEC1	666	Q9Y238
MKTNTAVRPYCFIEF	SEC22A	101	Q96IW7
EYKTTKADIQMPFTC	ALCAM	206	Q13740
FQYIREICLSDSPMV	GARNL3	641	Q5VVW2
FEMPDYNIETAKRVC	DNAH5	3386	Q8TE73
ACYSTVVTPKMLVNF	OR5T3	101	Q8NGG3
PTETCFEEAQKIVYM	RGS13	116	O14921
YVEMKFTLRDCNSIP	EPHA6	101	Q9UF33
YPVMKLSCIDTTINE	OR10J5	181	Q8NHC4
YHSQSPSMCDRKEFV	FOXF1	331	Q12946
FYKTADISQMLVCTA	TAF7L	171	Q5H9L4
CYFPMFVSQSALEKE	EPRS1	1076	P07814
VCTPEKVTKRMYDSF	SESN1	441	Q9Y6P5
DVQVPTSVKDMRYCQ	SMCHD1	1111	A6NHR9
SLKMAYVSKRCTPND	SNTA1	216	Q13424
TCDEFNGVPSYMKSR	SKA1	141	Q96BD8
MPFCNTTEFRDKYQA	SAXO1	266	Q8IYX7
SFYMQRCPEDSRLTE	NARS1	446	O43776
NFPKYDSNKMRVCIS	TDRD15	1006	B5MCY1
FTPRSIYMEASTVDC	LRRN3	41	Q9H3W5
TVMVDCIDFSPYNIK	RIF1	761	Q5UIP0
PTIVCTSFKKNRFYM	PPWD1	436	Q96BP3
VVFPYTSKSCMRAVL	RHOBTB2	541	Q9BYZ6
KSNELVMSCPYFRNE	SIPA1L1	406	O43166
SLEFYSPEACRSMKL	SCARB1	271	Q8WTV0
RCLYDDFMAQTTTKE	SRCAP	866	Q6ZRS2
SGMRVAFPDTKKTYC	ABHD17B	196	Q5VST6
TPYNIMVLVSTFCDK	CHRM5	456	P08912
MVPSNENCRKTYDTT	CCDC136	751	Q96JN2
VSLFMCYEGDPEKTA	ACSM1	426	Q08AH1
ENSNRTCSMPYAKLE	APC	941	P25054
NFTDTSLMYPEDTCK	TGIF1	336	Q15583
LFCPVSKMEAKNSYV	TRAF2	471	Q12933
RYVMPSCESDARAKT	SMOC1	286	Q9H4F8
PYKCTDCERAFTKMV	ZNF624	611	Q9P2J8
IVSADCQIMKDVPSY	ZFHX4	1796	Q86UP3
SFPRNEREICMYSSF	ZSWIM5	101	Q9P217
SVCSMRQPDLKYFDN	ZNF639	41	Q9UID6
FYVESRSMFCNLEPV	VPS35L	656	Q7Z3J2
CFVFQENSSEMPKLT	MTREX	911	P42285
ARKPTVCESEIRAYM	SPEG	1686	Q15772
VMTASCKSPVRTYER	TRAPPC14	371	Q8WVR3
SFRPLTAEMYQAVCE	SLC27A5	671	Q9Y2P5
TLSFVFMYAKCENEP	SLCO4C1	466	Q6ZQN7
TMQFEPSTMVYDACR	TLN1	16	Q9Y490
REKMDDTSLYNTPCV	STYXL2	101	Q5VZP5
RPSQLIYKCSCEMVF	ZNF592	856	Q92610
PACFYTVSRKEATEM	STAP1	176	Q9ULZ2
FTKLYQIPQTDMAEC	NF1	231	P21359
CYRDMSSFPETKAEK	PLCG1	976	P19174
KMTSQYPFEAETPEC	RXFP1	81	Q9HBX9
ILSYKMSQFCPSDQV	TEX11	661	Q8IYF3
EACFPESVKYTQQTM	VWA5A	336	O00534
NMSASCKEIVDSYLP	PSAP	101	P07602
CPFDVTMQKAITYFE	PSME4	201	Q14997
MESPKCLYSRITVNT	PRO0628	1	Q9UI54
TMYSVEYTPKRQEIC	SAXO2	351	Q658L1
CPCKVSYDVTSARDM	ROCK1	1281	Q13464
LSKRYFDTECVPMNF	SERPINA10	181	Q9UK55
EMTENKYVCFSALTI	TMEM262	76	E9PQX1
TRYFPDETINACKTM	TRPM1	1421	Q7Z4N2
MYECNPVEKSINSSS	ZNF677	211	Q86XU0
RMDVFYLQPECSSST	ZMYM2	1321	Q9UBW7
SELVYLQSSPDFCMK	WNT11	271	O96014
SNTLDDYMSCFRTPV	TTK	456	P33981
DYMSCFRTPVVKNDF	TTK	461	P33981
TPTEFRECDYNKFMS	S100A3	46	P33764
CMKSFRQSLYPALSE	ZNF597	301	Q96LX8
YELCTPELQEKMVSF	USP14	356	P54578
YQDMKSAVITPCSHF	RNF145	541	Q96MT1
PASDEIKTLQRYMCS	TENT5A	306	Q96IP4
MGNYKSRPTQTCTDE	TNNI3K	1	Q59H18
MAPEVFTQCTRYTIK	TNNI3K	631	Q59H18
RYTDINMEDFKCPIF	TOPBP1	186	Q92547
KAFCQPSTLTRYKRM	ZNF726P1	81	Q15940
GRSFMQVLCEKYSPE	TBCEL	6	Q5QJ74
FMEYVKRFVVSCVPS	USP33	546	Q8TEY7
ESTEIMKRPKYCSSD	TTLL7	536	Q6ZT98
TNETPYFMKSIDCIR	XRCC5	626	P13010
DRNCLEVLPTKMSYA	UBR5	2091	O95071
LDSAFRCMSSKGPVY	YTHDF1	421	Q9BYJ9
FKDMDKQCTVYPVSS	TMC7	206	Q7Z402
LKSCFNDYRTPTMLE	ZFHX3	2961	Q15911
SSYAKVSICLPMDTE	TSHR	561	P16473
SFPRSEREICMYSSL	ZSWIM4	71	Q9H7M6
ISPRDSTKAICMYCV	ZBED4	126	O75132
KLEYQFVSSECPSMN	VPS13D	1081	Q5THJ4
HYTSRQLCPTDKTME	MYO1G	496	B0I1T2
PIMVTKQLEDTTAYC	MYBPC1	341	Q00872